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ABSTRACT 
ABSTRACT 
Dinuclear transition metal complexes have attracted attention owing to their potential 
applications in the diverse fields of chemistry and biology. They are used as model 
systems for the active centers of many metalloenzymes and as successful devices to host 
and carry small molecules or ions. Although highly active dinuclear complexes have been 
reported in past decade, most of these complexes have their own substrate, mechanism or 
pH selectivity, thus the development of new functional models arose great interest 
Dinuclear complexes are capable to bind two metal ions in close proximity and permit 
them to interact or cooperate in their molecular framework, which is responsible for 
peculiar properties viz. optical, magnetic and mimics of catalytic active center in 
metalloenzymes in a number of biologically important processes. These processes extend 
from electron transfer to O2 transport or activation. Catechol oxidase is one such example 
which also contains nitrogen rich dinuclear copper centers in their active site and mediate 
the oxidation of catechols to quinones. 
Dinuclear centers have preference over mononuclear ligands as they are more efficient 
substrate binders, have double lewis acid activation due to the presence of two metal 
centers and may accelerate the rate of catalytic reaction as they share the tasks necessary 
to accomplish a given function. 
Transition-metal compounds that bind to DNA in a covalent or noncovalent fashion 
induce DNA strand scission have potential applications as tools for probing biomolecular 
structure and function, as cytotoxic agents in cancer chemotherapy. Kinetic lability or 
inertness toward ligand substitution is a major determinant that controls the covalent 
interactions of a metal complex with biological target molecule. DNA is the primary 
target molecule for most anticancer and antiviral therapies according to cell biology. 
Investigations of the interaction of DNA with small molecules or drug derivatives are 
basic in the design of new type of pharmaceutical molecules. 
Metal-based pharmaceuticals are receiving ever-increasing recognition for their roles in 
inhibiting the growth of cancer cells and destroying other microorganism, metal ions piay 
a key role in synthetic and natural metalloantibiotics as they are involved in specific 
interactions of these antibiotics with proteins, membranes, nucleic acids ^  and other 
biomolecules. For example, the binding of Fe/Co-BLM (BLM = bleomycin), Fe/Cu-SN 
(SN = streptonigrin), Mg-quinolone, Mg-quinobenzoxazine and cisplatin with DNA 
impairs DNA functions. The structural and functional roles of metal ions in 
metalloantibiotics cannot be thus underestimated and demands extensive research. 
To rationalize these findings, we have synthesized new homodinuclear/heterodinuciear 
complexes and their interaction with calf thymus DNA has been studied by uv-visible 
spectroscopy, cyclic voltammetry, viscosity measurements and fluorescence studies. 
Various techniques like elemental analyses, conductance measurements, i.r, e.p.r, uv-vis 
and n.m.r spectroscopy were employed to characterize these complexes. 
A new dinudear ligand L', ethylene[00'-bis-salicylidene-P-diketone] bearing two 
symmetrical coordination sites was synthesised by the condensation of salicylaldehyde 
and acetylacetone, L, with 1,2-dibromoethane under reflux. The ligand L' in a 1:1 ratio 
was treated with CuCb and NiCb to yield the complexes, bis[00'-bis-salicylidene-P-
diketone copper(II)] chloride and bis[(90'-bis-salicylidene-p-diketone nickel(II)] 
chloride. The complexes were subsequently characterized by spectroscopic techniques, 
elemental analyses, i.r., ' H n.m.r., '^C n.m.r., uv-vis, e.p.r. spectroscopy, and conductance 
measurements. The conductance measurements in DMF reveal that the Cu(II) and Ni(II) 
complexes are ionic in nature. The spectral data support that both the Cu(II) and Ni(II) 
complexes acquire square-planar geometry. The dioxygen binding was studied 
spectrometrically by the oxidation of pyrocatechol with bis[(90'-bis-salicylidene-P-
diketone copper(II)] chloride in the presence of oxygen. The kinetic experiments were 
performed with dinuclear Cu(II) complex in DMF by monitoring the increase in the 
o-benzoquinone characteristic absorption band Q^M = 25,000 cm"') over time at pH 8.0 
in the presence of pyrocatechol at 25 '^ C. The kinetic parameters Vmax and KM were 
determined on the Michaelis-Menten Approach. Redox behavior of the dinuclear 
copper(II) complex was investigated by cyclic voltammetry in the presence of 0 ; with 
the pyrocatechol (substrate) and also without the substrate. The large difference in 
potentials E*^  are indicative of reversible oxygen binding of the complex and distinct 
catalytic activity. 
Novel dinuclear complexes [C22H52Nio02Cu2].(C104)4 and [C22H52Nio02Ni2].(C104)4 
have been synthesized as model systems for the catechol oxidase active site enzymes to 
understand the aspects of structure/reactivity and characterized by various spectroscopic 
techniques, i.r., n.m.r., e.p.r., uv-vis and conductance measurements. Spectral data and 
conductance measurements reveal that the dinuclear complexes are consistent with 
square-planar geometry and are ionic in nature. The catalytic activity of the dinuclear 
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Cu(II) complex in presence of pyrocatechol was determined spectrometrically by 
monitoring the increase of the o-benzoquinone characteristic absorption band at 
25,000 cm'' with respect to time in DMF saturated with molecular oxygen. The kinetic 
parameters Vmax (2.8 xlO'^  MS'') and KM (1.4 xlO'^ mM) have been determined by 
Michaelis-Menten model. Electrochemistry of the dinuclear Cu(II) complex has been 
studied in presence of molecular oxygen with pyrocatechol and without pyrocatechol at a 
scan rate of 0.1 Vs'' by cyclic voltammetry. On addition of pyrocatechol, complex shows 
a shift in Epc, Epa and E1/2 values with a new cathodic peak at 0.015 V. 
Many of the drugs have been known to exhibit increased anticancer activity when 
administered as metal complexes. While most antibiotics do not need metal ions for their 
biological activities, there are several antibiotics that require metal ions to function 
properly. Removal of metal ions thus results in deactivation and change in structure of 
antibiotics such as bleomycin, streptonigrin and albomycin, in other cases binding of 
metal ions to the antibiotic molecules gives rise to profound chemical and biochemical 
consequence which does not affect the structure of the drugs such as tetracycline, aureolic 
acids and quinolones. These families of antibiotics are termed as "metalloantibiotics". 
Metalloantibiotics are capable of specific protein-DNA interaction transcription is 
regulated to turn on or off to a specific biological process. The investigations of the 
interaction of DNA and the synthetic metal complexes derived from antibiotics can 
provide clues for rational design of DNA-specific future drugs. New dinuclear complexes 
of the type [cip(TPT)dtcM(II)].Cl where cip = ciprofloxacin, TPT = triphenyltin, 
dtc = dithiocarbamate and M(I1) = Cu(II) and Ni(II) have been synthesized and 
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characterized by elemental analyses, i.r., n.m.r., e.p.r., uv-vis spectroscopy and molar 
conductance. Spectroscopic studies suggest that the metal ion in these dinuclear 
complexes acquire square-planar geometry by coordination with the oxygen of pyridone 
moiety and one of the oxygen of carboxylic group. Uv-vis spectrometry, cyclic 
voltammetry, viscosity measurements and fluorescence studies have been carried out to 
assess the interaction of the complex [CaeHssNaFOsSaSnCuJ.Cl with calf thymus DNA. 
Absorption spectral studies show hyperchromism with increasing concentrations of calf 
thymus DNA. The binding constant of the complex to CT-DNA has been estimated to be 
Kb = 1.1 X 10^  M''. Relative viscosity of DNA decreases by increasing the concentration 
of the complex, indicating that the complex binds to DNA by the partial nonclassical 
intercalation model. The redox behaviour of the unbound and calf thymus DNA bound 
complex [C36H35N3F05S2SnCu].Cl in MeOH/HaO solution (5:95) was investigated by 
cyclic voltammetry. The cyclic voltammogram of the complex without DNA exhibits a 
well defined quasireversible redox wave Cu'VCu' attributed to one electron transfer 
process with E1/2 value of 0.041 V. On interaction with calf thymus DNA, the complex 
exhibits shift in E1/2 value corresponding to 0.015 V. The interaction of the complex 
[CseHasNsFOsSaSnCuJ.Cl with DNA was further confirmed by the fluorescence 
measurements. Fluorescence intensity of the complex was quenched with increasing 
concentration of CT-DNA, with a Stern-Volmcr quenching constant value of 4 xlO ^ M"'. 
Complex [CjeHaaNjFOsSaSn] and [C36Hj5N3F05S2SnCu].Cl have been screened for their 
antibacterial activity against gram-negative bacteria E.coli, the observed results revealed 
the complexes are more potent antibacterial agents in comparison to the test control 
parent drug (ciprofloxacin). 
The synthesis and characterization of new metal complexes with quinolone antibacterial 
agents are of great importance for understanding the drug-metal ion interaction and for 
their potential pharmacological use. New dinuclear complexes [C38H48F4Ni205Cu2].Cl2 
and [C38H48F4Ni205Ni2].Cl2 have been synthesized using sparfloxacin as a chelating 
agent, and characterized by various physico-chemical methods. On the basis of analytical 
and spectral data, square-planar geometry has been proposed for the dinuclear complexes. 
The DNA-binding properties of the dinuclear complex [C3gH4xF4Ni205Cu2].Cl2 has been 
investigated with uv-vis absorption, cyclic voltammetry, viscosity and fluorescence 
measurements. Hypochromism and a blue shift of 4 nm in the absorption spectra was 
observed, and an increase in the viscosity of calf thymus DNA indicates that the complex 
acts as a CT-DNA intercalator with an intrinsic binding constant value of 1.0 x 10^  M"'. 
This is further supported by the electrochemical behaviour of dinuclear Cu(II) complex 
before and after the interaction with calf thymus DNA. The cyclic voltammogram 
exhibits one electron quasireversible redox couple corresponding to Cu'VCu' at a scan rate 
of 0.1 Vs''. The shift in AEpand E1/2 values ascertain the interaction of calf thymus DNA 
with the complex. Fluorescence intensity of the dinuclear Cu(II) complex decreases 
steadily with increasing addition of CT-DNA, which provides supportive evidence for the 
strong binding of the complex with CT-DNA. 
VI 
SYNTHESIS AND BIOLOGICAL ACTIVITY 
OF NEW DINUCLEAR COMPLEXES 
OF NITROGEN AND OXYGEN 
CONTAINING LIGANDS 
N N w ^ N^ 
/ / 
Thesis submitted for the award of the degree of 
IDoctor of l^ijilosfopfjp 
'^ IN 
CHEMISTRY 
% I 
* - ^ * • ^ - * . v:^> 
/I 
BY 
SHAMIMA PARVEEN 
DEPARTMENT OF CHEMISTRY 
ALIGARH MUSLIM UNIVERSITY 
ALIGARH (INDIA) 
2005 
T6683 

Dr. (Mrs.) Farukh Arjmand 
Department of Chemistry 
Aligarh Muslim University, Aligarh-202002, India 
Phone No. 0571-703893 
E-mail: farukh_arjiTiand@yahoo.co.in 
Certificate 
The work embodied in this thesis entitled "Synthesis and biological activity of new 
dinuclear complexes of nitrogen and oxygen containing ligands" is the result of 
original research carried out by Mrs. Sltamima Parveen under my supervision and is 
suitable for the award of Ph.D. degree. 
^ -
FARUKH ARJMAND 
CONTENTS 
Page No. 
ACKNOWLEDGEMENT 
PUBLICATIONS 
ABSTRACT 
CHAPTER I: 
CHAPTER H: 
CHAPTER HI 
Introduction 
Experimental 
CHAPTER IV: 
Synthesis of new dinuclear dicopper(II) 
and dinickel(II) complexes; Kinetics of 
catechol oxidase and electrochemistry of 
dicopper(II) complex. 
Synthesis of 0,0-ethylene bridged bis-
metal lated macrocycles; Selective enzyme 
models for catecholase activity. 
Synthesis of dithiocarbamate ciprofloxacin 
derivatives; Antibacterial activity and 
interaction of heterodinuclear copper tin 
complex with calf thymus DNA. 
CHAPTER VI: Synthesis, characterization, electrochemistry 
and calf thymus DNA binding studies of 
dinuclear coppor( 11) coniplcv of sparfloxacin. 
CHAPTER V: 
i-vi 
1-22 
23-36 
37-54 
55-72 
73-92 
93-112 
REFERENCES: 113-131 
A CKNO WLED CEMENTS 
ACKNOWLEDGEMENT 
J^tartina ou tne name of ^y^Uan, tke most merciful ana beneuolent, u/ko has 
enaotea me to duomit this f^n.^UJ. thesis. 
^ feel areat pteaSure to express mu sincere and heartfelt aratitude to mu supervisor 
.Jjr. IrrlrS.I ^aruhh ..^rjmand for her able Guidance throuah out mu research 
u/orh. ^ t is onlu because of her constant encouraaement, motivation and 
Supervision that Jr have been a to complete this thesis. 
^ reaiiu feel proud to aDr. J^artaJ ^abaSSum for most needed and valuable 
SuaaestionS at mu critical times without which it would have been a difficult tash 
to complete. 
ilflu sincere thanks are also due to L^hairman, rrof. ^J\abir-ud-.cJjin, 
artment of L^hemistru for providina me the neceSSaru research facilities. 
Jr am grateful to J U ' J / ll/lumbai and l\..^.Jr.(^, (^..Jj.M.Jr. jLuchnow for 
providing me the C^.J-^.r\., .3.K., L^,,J4, rl & rl. I If (.IK. facilities. 
^ am I'crii inncli tliaiihful to tnu huihand .J-Jr. J^amiullali aruz tnij motlier in-law 
frlrA. ^yvhlininn rjiia for tlieir contlnuoui tnorat iuppoft, encoui-agefnent and 
patience all tlirouglwut inu tlieiii worn ana alio mu aaugliter ^aboor ^atitna 
wlw cheered me up wiienever ^ felt exIiMUited. 
Jt mill he liicililii iinjiiit if ^ fail to conueu inu tlianhi to inu parenti ana brotlieri, 
i< lie //<((/ lu'l/jed ana .Supported me a lot. 
.^inallii, J/ am tlianhful to all mil colleagues tor tlieir cooperation during tlie 
entire reAcarcn icori?. 
PUBLICATIONS 
Publications 
1. Synthesis of new dinuclear dicopper(II) and dinickel(II) complexes; Kinetics of 
catechol oxidase and electrochemistry of dicopper(II) complex, 
Farukh Arjmand, Shamima Parveen and Sartaj Tabassum, Transition Met. Chem.. 
(in press, 2005). 
2. Synthesis of 0,0-ethylene bridged bis-metallated macrocycles; Selective enzyme 
models for catecholase activity, 
Shamima Parveen, Farukh Arjmand and Sartaj Tabassum, Transition Met. Chem.. 
(Communicated). 
3. Synthesis of dithiocarbamate ciprofloxacin derivatives; Antibacterial activity and 
interaction of heterodinuclear copper tin complex with calf thymus DNA, 
Shamima Parveen, Farukh Arjmand and Sartaj Tabassum, Eur. J. Med. Chem., 
(Communicated). 
ABSTRACT 
ABSTRACT 
Dinuclear transition metal complexes have attracted attention owing to their potential 
applications in the diverse fields of chemistry and biology. They are used as model 
systems for the active centers of many metalloenzymes and as successful devices to host 
and carry small molecules or ions. Although highly active dinuclear complexes have been 
reported in past decade, most of these complexes have their own substrate, mechanism or 
pH selectivity, thus the development of new functional models arose great interest. 
Dinuclear complexes are capable to bind two metal ions in close proximity and permit 
them to interact or cooperate in their molecular framework, which is responsible for 
peculiar properties viz. optical, magnetic and mimics of catalytic active center in 
metal loenzymes in a number of biologically important processes. These processes extend 
from electron transfer to O2 transport or activation. Catechol oxidase is one such example 
which also contains nitrogen rich dinuclear copper centers in their active site and mediate 
the oxidation of catechols to quinones. 
Dinuclear centers have preference over mononuclear ligands as they are more efficient 
substrate binders, have double lewis acid activation due to the presence of two metal 
centers and may accelerate the rate of catalytic reaction as they share the tasks necessary 
to accomplish a given function. 
Transition-metal compounds that bind to DNA in a covalent or noncovalent fashion 
induce DNA strand scission have potential applications as tools for probing biomolecular 
structure and function, as cytotoxic agents in cancer chemotherapy. Kinetic lability or 
inertness toward ligand substitution is a major determinant that controls the covalent 
interactions of a metal complex with biological target molecule. DNA is the primary 
target molecule for most anticancer and antiviral therapies according to cell biology. 
Investigations of the interaction of DNA with small molecules or drug derivatives are 
basic in the design of new type of pharmaceutical molecules. 
Metal-based pharmaceuticals are receiving ever-increasing recognition for their roles in 
inhibiting the growth of cancer cells and destroying other microorganism, metal ions play 
a key role in synthetic and natural metalloantibiotics as they are involved in specific 
interactions of these antibiotics with proteins, membranes, nucleic acids and other 
biomolecules. For example, the binding of Fe/Co-BLM (BLM = bleomycin), Fe/Cu-SN 
(SN = streptonigrin), Mg-quinolone, Mg-quinobenzoxazine and cisplatin with DNA 
impairs DNA functions. The structural and functional roles of metal ions in 
metalloantibiotics cannot be thus underestimated and demands extensive research. 
To rationalize these findings, we have synthesized new homodinuclear/heterodinuclear 
complexes and their interaction with calf thymus DNA has been studied by uv-visible 
spectroscopy, cyclic voltammetry, viscosity measurements and fluorescence studies. 
Various techniques like elemental analyses, conductance measurements, i.r, e.p.r, uv-vis 
and n.m.r spectroscopy were employed to characterize these complexes. 
A new dinuclear ligand L', ethylene[00'-bis-salicylidene-P-dikeione] bearing two 
symmetrical coordination sites was synthesised by the condensation of salicylaldehyde 
and acetylacetone, L, with 1,2-dibromoethane under reflux. The ligand L' in a 1:1 ratio 
was treated with CuCb and NiCb to yield the complexes, bis[00'-bis-salicylidene-P-
diketone copper(II)] chloride and bis[0(7-bis-salicylidene-P-diketone nickel(II)] 
chloride. The complexes were subsequently characterized by spectroscopic techniques, 
elemental analyses, i.r., ' H n.m.r., '^C n.m.r., uv-vis, e.p.r. spectroscopy, and conductance 
measurements. The conductance measurements in DMF reveal that the Cu(Il) and Ni(ll) 
complexes are ionic in nature. The spectral data support that both the Cu(II) and Ni(Il) 
complexes acquire square-planar geometry. The dioxygen binding was studied 
spectrometrically by the oxidation of pyrocatechol with bis[0(9'-bis-salicylidene-P-
diketone copper(II)] chloride in the presence of oxygen. The kinetic experiments were 
performed with dinuclear Cu(II) complex in DMF by monitoring the increase in the 
o-benzoquinone characteristic absorption band (>.max = 25,000 cm"') over time at pH 8.0 
in the presence of pyrocatechol at 25 C. The kinetic parameters Vn,a\ and KM were 
determined on the Michaelis-Menten Approach. Redox behavior of the dinuclear 
copper(II) complex was investigated by cyclic voltammetry in the presence of O: with 
the pyrocatechol (substrate) and also without the substrate. The large difference in 
potentials E° are indicative of reversible oxygen binding of the complex and distinct 
catalytic activity. 
Novel dinuclear complexes [C22H52Nio02Cu2].(C104)4 and [C22H52Nio02Ni2].(€104)4 
have been synthesized as model systems for the catechol oxidase active site enzymes to 
understand the aspects of structure/reactivity and characterized by various spectroscopic 
techniques, i.r., n.m.r., e.p.r., uv-vis and conductance measurements. Spectral data and 
conductance measurements reveal that the dinuclear complexes are consistent with 
square-planar geometry and are ionic in nature. The catalytic activity of the dinuclear 
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Cu(II) complex in presence of pyrocatechol was determined spectrometrically by 
monitoring the increase of the o-benzoquinone characteristic absorption band at 
25,000 cm'' with respect to time in DMF saturated with molecular oxygen. The kinetic 
parameters V a^x (2.8 xlO"^  MS'') and KM (1.4 xlO"^ mM) have been determined by 
Michaelis-Menten. model. Electrochemistry of the dinuclear Cu(II) complex has been 
studied in presence of molecular oxygen with pyrocatechol and without pyrocatechol at a 
scan rate of 0.1 Vs"' by cyclic voltammetry. On addition of pyrocatechol, complex shows 
a shift in Epc, Epa and E1/2 values with a new cathodic peak at 0.015 V. 
Many of the drugs have been known to exhibit increased anticancer activity when 
administered as metal complexes. While most antibiotics do not need metal ions for their 
biological activities, there are several antibiotics that require metal ions to function 
properly. Removal of metal ions thus results in deactivation and change in structure of 
antibiotics such as bleomycin, streptonigrin and albomycin, in other cases binding of 
metal ions to the antibiotic molecules gives rise to profound chemical and biochemical 
consequence which does not affect the structure of the drugs such as tetracycline, aureolic 
acids and quinolones. These families of antibiotics are termed as "metalloantibiotics". 
Metalloantibiotics are capable of specific protein-DNA interaction transcription is 
regulated to turn on or off to a specific biological process. The investigations of the 
interaction of DN.^ and the synthetic metal complexes derived from antibiotics can 
provide clues for rational design of DNA-specific future drugs. New dinuclear complexes 
of the type [cip(TPT)dtcM(II)].Cl where cip = ciprofloxacin, TPT = triphenyltin, 
dtc = dithiocarbamate and M(II) = Cu(II) and Ni(II) have been synthesized and 
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characterized by elemental analyses, i.r., n.m.r., e.p.r., uv-vis spectroscopy and molar 
conductance. Spectroscopic studies suggest that the metal ion in these dinuclear 
complexes acquire square-planar geometry by coordination with the oxygen of pyridone 
moiety and one of the oxygen of carboxylic group. Uv-vis spectrometry, cyclic 
voltammetry, viscosity measurements and fluorescence studies have been carried out to 
assess the interaction of the complex [CseHssNaFOsSaSnCuJ.Cl with calf thymus DNA. 
Absorption spectral studies show hyperchromism with increasing concentrations of calf 
th>mus DNA. The binding constant of the complex to CT-DNA has been estimated to be 
Kb - 1.1 X 10""' M"'. Relative viscosity of DNA decreases by increasing the concentration 
of the complex, indicating that the complex binds to DNA by the partial nonclassical 
intercalation model. The redox behaviour of the unbound and calf thymus DNA bound 
complex [C36H35N3F05S2SnCu].Cl in MeOH/H20 solution (5:95) was investigated by 
cyclic voltammetry. The cyclic voltammogram of the complex without DNA exhibits a 
well defined quasireversible redox wave Cu'VCu' attributed to one electron transfer 
process with E\a value of 0.041 V. On interaction with calf thymus DNA, the complex 
exhibits shift in E1/2 value corresponding to 0.015 V. The interaction of the complex 
[C36H35N3F05S2SnCu].Cl with DNA was further confirmed by the fluorescence 
measurements. Fluorescence intensity of the complex was quenched with increasing 
concentration of CT-DNA, with a Stcrn-Volmcr quenching constant value of 4 xlO ^ M''. 
Complex [C36H32N3F03S2Sn] and [C3ftH35N3F05S2SnCu].Cl have been screened for their 
antibacterial activity against gram-negative bacteria E.coli, the observed results revealed 
the complexes are more potent antibacterial agents in comparison to the test control 
parent drug (ciprofloxacin). 
The synthesis and characterization of new metal complexes with quinolone antibacterial 
agents are of great importance for understanding the drug-metal ion interaction and for 
their potential pharmacological use. New dinuclear complexes [C38H48F4Ni205Cu2].Cl2 
and [C38H48F4Ni205Ni2].Cl2 have been synthesized using sparfloxacin as a chelating 
agent, and characterized by various physico-chemical methods. On the basis of analytical 
and spectral data, square-planar geometry has been proposed for the dinuclear complexes. 
The DNA-binding properties of the dinuclear complex [C38H48F4Ni205Cu2].Cl2has been 
investigated with uv-vis absorption, cyclic voltammetry, viscosity and fluorescence 
measurements. Hypochromism and a blue shift of 4 nm in the absorption spectra was 
observed, and an increase in the viscosity of calf thymus DNA indicates that the complex 
acts as a CT-DNA intercalator with an intrinsic binding constant value of 1.0 x 10^  M"'. 
This is further supported by the electrochemical behaviour &f dinuclear Cu(II) complex 
before and after the interaction with calf thymus DNA. The cyclic voltammogram 
exhibits one electron quasireversible redox couple corresponding to Cu'VCu' at a scan rate 
of 0.1 Vs''. The shift in AEpand E1/2 values ascertain the interaction of calf thymus DNA 
with the complex. Fluorescence intensity of the dinuclear Cu(II) complex decreases 
steadily with increasing addition of CT-DNA, which provides supportive evidence for the 
strong binding of the complex with CT-DNA. 
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CHAPTER I 
INTRODUCTION 
INTRODUCTION 
Nature provides numerous multimetallic protein complexes tliat perform an extraordinary 
array of catalytic transformations, few of which had been anticipated or reproduced in 
nonprotein systems. These continuing biological discoveries have inspired coordination 
chemists to develop the area of research which is relevant to biology from inorganic point 
of view-specialized area of bioinorganic chemistry. 
Search for functional analogues of proteins is not an easy lask because the function 
performed by the proteins is not only controlled by the immediate coordination sphere 
but is also affected by the larger protein structure. However, the study of analogues of 
metalloproteins is quite informative as these studies can help to understand the reactivity 
pattern of the proteins. 
(Figure-1) depicts a list of bimetallic binding sites in various proteins [1-10], the 
functions which they carry and serves to illustrate a number of features of the binding 
sites. The bimetallic protein complexes are constructed using a limited number of ligands. 
Coordination chemistry unlike biological systems provides multimetallic complexes with 
a large variety of ligands, structures, and metals. Consequently it is possible to study 
reactivity patterns unavailable in the biological systems. 
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The design of dinuclear ligands that form bimetallic complexes are categorized by the 
bridging group that spans the two metals. The bridging ligands are of three types, those 
that have single-atom bridges, those with two-atom bridges and bimetallic complexes 
with three-atom bridges. 
Bimetallic complexes formed with one or two-atom bridges are of the types as shown in 
(Figure-2, a-c). The bridging structures (a) and (b) are formed without strain but bridging 
system (c) carries considerable strain because of angle deformation. Common bridging 
units are, carboxylate [11-13], pyrazolate [14-15], trizolate [16], oxadiazole [17-18], 
thiadiazole [19]. pyridazine [20], phenolate anion [21], diaza heterocyclic bridges 
[22-25]. 
-Y 
V / \ 
\ / \ / 
Y Y Y Y 
(a) (b) (c) 
Figure-2. 5/7V/if//;e svsicms for bimelallic complexes. 
Lippard el al. |26-27) iiavc developed a number of dinucleating ligands which resemble 
respiratory protein hemerythrin. carrying two carboxylate bridges, several other attempts 
have been made to generate such dicarboxylate ligands which will reproduce the metal 
binding in the proteins [28-30], the structures of a variety of ligands with bridging 
dicarboxylate capable of forming bimetallic complexes are shown in (Figure-3). The 
di-Cu'"^ complex of the ligand (a), [Cu2(a)(N3)2]CI04 was synthesized and characterized 
by X-ray crystallography [31 ]. 
o^pS 
(a) (b) 
ph leep 
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- \ J— r 
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Figure-3. Dicarboxylate bridging ligands. 
One of the most interesting property of some of these dinuclear complexes is their ability 
to react with O2 reversibly [32]. Bimetallic complexes of cobalt and iron have generated 
dioxygen complexes, with some binucleating alkoxide bridging iigands. Ligands of the 
type as shown in (Figure-4) with Co'"^  acetate gave complexes with the formula [Co2^^(|i-
acetate) ligand]""^  where the Co"^ ions are five coordinate. All of these complexes absorb 
O2 to give stable dioxygen complexes. 
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Figure-4. Ligands forming dinuclear complexes. 
A di-iron dioxygen complex [Fe2(^-02)ligand] where ligand is a binucleating alkoxide 
bridging group has been reported [33]. The dioxygen binding to this complex is 
irreversible in contrast to a similar series of di-Fe^^n-carboxylate complexes, 
incorporating the ligands Figure-4 (e) and (f) for which at -20 °C in CH3CN or CH2CI2 
solutions O2 uptake is reversible over several cycles [32]. The crystal structure of this 
complex reveals that two Fe'^ ions are five-coordinate. Presumably upon Oj uptake, the 
iron atoms become six-coordinate and the structure of the dioxygen adduct resembles 
other cobalt compounds. 
The complex ions [Cu2"^ (L)2]"* where L = l,3-bis(2-benzimidazolyl)-2-propanol (Hbbp) 
and [Cu2"^(L)2]'^  where L - l,5-bis(2-benzimidazolyl)-3-pentanol (Hbbpen) 
were examined for catecholase activity using 3,5-di-tert-butyl catechol, as a substrate 
[34]. The llrst complex did not react with butyl catechol while the second complex 
reacted to give the o-quinone as shown in equation (1). 
OH 
2Cu 2* yW° 
OH ^ \ " S ^ o ('^  
The difference in reactivity between the two complexes was ascribed to the greater 
chelate ring size provided by the ligand which will enhance the stability of the Cu"^  state. 
The ion [Cu2"^(L)2]'^ where L = l,3-bis(2,4-dimethyl pyrazoIe)-2-propoxy anion [35] 
was found to polymerize 2,6 dimethyl phenol as shown in equation (2). 
OH + O2 
catalyst 
base 
H 
/ 
\ // OT 
(2) 
2+ Similarly, a di-Cu* complex ion was found to promote the hydrolysis of phosphodiester 
bond [36] whereas it was established that the Cu*^ ions per ligand were required for this 
hydrolysis reaction, the structure of the active complex was not determined. 
In metalloenzymes, Cu exists in mononuclear and coupled multinuclear configurations 
that have evolved to facilitate redox process. The predominant roles of most Cu enzymes 
are O2 activation and subsequent substrate oxidation. Biological Cu serves exclusively as 
le" shuttle, alternating between Cu(I) and Cu(II). The Cu(lll) oxidation stale is ccncrally 
considered to be inaccessible because of the highly positive Cu(lll)/Cu(ll) redox 
potentials that result from ligation of typical amino acid side chains such as imidazoles 
and phenolate ions [37]. 
Cu-containing enzymes that activate Oi function as dioxygenases, monooxygenases, and 
oxidases are shown in (Figure-5). The nuclearity of the active site does not correlate 
directly with the type of reactivity, for example, mononuclear Cu enzymes perform all 
three types of reactions. 
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Figure-5. Copper enzymes and proteins that activate O2 
The binuclear Cu protein hemocyanin and the Cu enzymes, tyrosinase and catechol 
oxidase bind O2 reversibly by forming spectroscopicaliy similar peroxide species [38-40]. 
In oxyhemocyanin O2 is reduced by 2e" to form the peroxide ion, but it does not oxidize 
catechols to quinones as oxytyrosinase and oxycatechol oxidase (Figure-5). Accessibility 
of substrates to the oxygenated active site is responsible for the differences in reactivity 
[41-42]. 
The coordination environments of Cu in these enzymes and proteins provide important 
insights into the structural attributes that are required for function. Geometric preferences 
of Cu centers are discussed below: 
Cu(I). Univalent Cu has a d'° electronic configuration and its geometry is dominated by 
steric factors or structural constraints in the case of polydentate ligands. The high lability 
and geometric flexibility of Cu(l) complexes allow numerous geometries, tetrahedral or 
trigonal-monopyramidal, four-coordinated complexes are most common, T- or Y-shaped 
three-coordinated and linear two-coordinated complexes are frequently observed. 
Five coordinated Cu(I) complexes are rare [43-49]. 
Cu(II). The d' configuration of Cu(II) in an octahedral field leads to a significant 
Jahn-Teller distortion that usually manifests itself as an axial elongation, consistent with 
the lability and geometric flexibility of Cu(Il) complexes. Hence, Cu(II) complexes 
commonl)' have square-planar or square-pyramidal geometries with ligands weakly 
associated in the axial position at a distances of 2.3-2.6 A . In such complexes, the single 
unpaired electron is localized in the dx -y orbital. Trigonal-bipyramidal coordination of 
Cu(II) is also possible, in which case the electronic ground state has usually the unpaired 
electron in the dz^  orbital. The bridged compounds in which two or more Cu(II) ions are 
linked by anionic ligands (for example, oxide, hydroxide) exhibit either an 
antiferromagnetic or ferromagnetic coupling between the Cu(II) ions [50-51]. 
Cu(III). Discrete complexes of Cu(III) are much less common than those of Cu(I) and 
Cu(II). Such complexes are generally stabilized by strongly basic, anionic ligands that 
accommodate a square-planar geometry [52-56] or axial ligation to these square-planar 
geometry complexes increases their oxidizing potential [57]. While a d Cu(III) center 
can exist in a high spin state (S = 1) [58-59] all discrete Cu(III) complexes with oxygen 
ligation are low-spin and diamagnetic. 
The diversity of Cu/02 species results from the formal oxidation state tunability of the 
Cu centers and the 02-derived ligands. Cu(ll) or Cu(IIl) can be ligated to superoxide 
(le'), peroxide (2e') or oxide (4e') ions. X-ray crystallography is the best technique for 
confirming the structures of these complexes, its limited success in the Cu/O: area is 
commensurate with the difficulty of working with thermally sensitive complexes. The Cu 
K-edge extended X-ray absorption fine structure (EXAFS) analysis of Cu/02 complexes, 
both in solution and in the solid state provides an alternative approach to obtain key 
structural parameters such as Cu—Cu and Cu-O/N distances [60-621. 
The UV-vis spectra of many Cu/02 species exhibits intense oxygen to Cu charge transfer 
(CT) absorptions, which are consistent with the presence of highly covalent Cu-0 bonds. 
These transitions are often characteristic and in such cases show distinct topological 
Cu/02 arrangements. The sensitivity of these absorption features to subtle structural 
changes, together with the simplicity of this technique, makes UV-vis spectroscopy a 
powerful experimental tool. 
There is much chemical and biochemical interest in metal complexes with a variety of 
amino polyalcohols. Aminoaicohols offer many possibility for metal-ion coordination, 
providing various N, O environments [63-65]. A number of pro-ligands derived from 
l,n-diaminoalcohols and bearing pyridyl [66], phenolic [67], 6-methylpyridyl [68] and 
1-ethylbenzimidazolyl [69] groups have been synthesized and used to prepare a range of 
dinuclear transition metal complexes. The most widely studied of these pro-ligands is 
l,3-bis(bis-pyridin-2-ylmethylamino)propan-2-ol which has been used in modelling 
studies related to the metailobiosites involved in PS II [70-71] and hydrolases [72-73] 
and for deoxygenate binding studies [74-75]. Biologically amino sugars, naturally 
occurring aminoalcohol analogues may act as powerful ligands for metal ions like Cu(ll) 
with the amino group usually providing an efficient anchor for the metal ion [76-78]. 
The studies on the linear aminoaicohols (4-aminobutanetriols and 5-aminopentanetetrols) 
have shown that although [79] the nitrogen acts as an anchoring binding site, the adjacent 
deprotonated hydroxyl groups act as bridges between two metal ions and has critical 
influence on the coordination equilibria, structures and stabilities of the complexes 
formed. A series of diaminoalcohols 1,5-diaminotriols and 1,6-diaminotetrols have been 
synthesized and their coordination abilities towards Cu(II) studied by potentiometry and 
spectroscopic techniques (UV/vis, EPR and CD) [80]. Both amino groups act as 
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anchoring sites for two metal ions (Figure-6). Thus two independent NHi, ©"chelates are 
formed leading to dimeric complexes in which two metal ions are bound to two 
N-terminal atoms of the 1,5- or 1,6-diaminoalcohols. 
Cu2a4L2 
HOHC CHOH HOHC H CHOH 
CHOH 
Figure-6. Anchor in f^ sites for t^vo metal ions. 
Interaction of metal ions with drugs, especially antibiotics has been the aim of many 
research studies sjncepast few years, many reviews have appeared in this field [81-83]. 
The fluoroquinolone agents are a group of antibacterials (Figure-7) currently used in 
various kinds of infections [84] and show better performance against gram-negative 
organism than gram-positive pathogens. Some prominent members of liiis family 
especially, ofloxacin and ciprofloxacin have shown interactions with several metal ions. 
Co(II), Ni(II), Cu(ll) and Zn(ll) [85-90|. 
NilJdixicAcid NoriloMda 
NIIj 0 
O uL XJ Y Y"j ' I 
Ofloucin CiiKufluxiicia SpaiflouciD 
COjH 
Figure-7. Chemical sirucliires of representative quiiwlones. 
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Ciprofloxacin (l-cycloproyl-6-fluoro-4-oxo-7-(l-piperazinyl)-l,4-dihydroquinoline-3-
carboxylic acid) is currently employed fluoroquinolone with the widest clinical use [91]. 
Its complex forming ability with several metal cations has been extensively explored 
[92-95] and mostly forms a bond with carboxyl group at position 3 and ring carbonyl 
group at position 4 (Figure-8). 
0 Q 
Figure-8. Structure of ciprofloxacin. 
The ciprofloxacin-copper(II) complex was studied by different physico-chemical 
methods. The crystal structure of [Cu(cf)2]Cl2.6H20 was determined [96] and this 
complex was also studied in solution [97]. The stability constants, NMR relaxation rates 
were also determined. Similarly, the reaction between ciprofloxacin and Co(II) was also 
studied in aqueous medium, it was observed that the ability of ciprofloxacin to form 
metal complexes is highly dependent on the pH value of the solution, it coordinates to the 
metal in the pH range above 7 [98-100]. The complex Co(c02-3H2O was isolated in its 
pure from at pH = 8. 
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Marija et al. isolated two novel Zn(II) complexes of ciprofloxacin. The crystal structure 
of the compound (I) C17H19N3O3F2. ZnCU. 2H2O was determined by X-ray diffraction, 
which revealed the structure to be ionic, consisting of a tetrachlorozincate(n) dianion and 
two protonated, monocationic ciprofloxacin molecules. Compound (11) Zn(c02- 3H2O 
was obtained as microcrystals from an aqueous solution of ciprofloxacin hydrochloride 
and zinc sulphate adjusted to pH = 8 by the addition of sodium hydroxide. 
Uv-vis spectroscopy was used to investigate the pH dependence of the complexation of 
Zn(ll) with ciprofloxacin in aqueous solution. The absorption maxima for an aqueous 
solution of ciprofloxacin at pH = 2 appeared at 277, 316 and 328 nm. On increasing the 
pH. the maximum at 277 nm shifted to lower values and the maxima at 316 and 328 nm 
shifted to higher values (Figure-9). These changes are attributed to ionization of the 
carboxylic group by the removal of a proton [101]. 
wavBlengtli/nm 
Figure-9. Uv-vis spectra of the solutions of (a) ciprofloxacin (b) ciprofloxacin and 
zinc sulphate at pH =8 
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Sparfloxacin (5-amino-l-cyclopropyl-7(cis-3,5-dimethyl-l-piperazinyl)-6,8-difluoro-l,4-
dihydro-4-oxo-3-quinoline carboxylic acid) is a new addition to the class of 
fluoroquinolones, which is used in the treatment of cuttaneous allergy, lung infection and 
urinary tract infection [102]. and shows intensive and efficient antibacterial activity 
compared to the common quinolones [103]. 
Although there is a scarcity of literature on complexation of sparfloxacin, a few reports 
by Jain et al. on Co(ll)-sparnoxacin have appeared and describe the characterization of 
the complex by polarographic and spectral methods [104]. The antibacterial studies on 
the drug and its complex were carried out against various pathogenic bacteria, the 
increased potency of Co(ll)-sparfloxacin complex was recommended in therapy for its 
possible use as anti-HlV agent. 
There is paucity of literature on interaction of the metal complexes of quinolones with 
calf thymus DNA, yet binding of fluoroquinolones with calf thymus DNA has been a 
subject of interest for many researchers [105-106]. 
Fluoroquinolones (FQs), lomefloxacin (LOM) and enoxacin (ENX) binding to calf 
thymus DNA [107] have been investigated at neutral pH through several spectroscopic 
techniques (Uv-vis, induced circular dichroism. fluorescence studies etc.). Significant 
hypochromic effects, accompanied by change in the shape of the absorption bands were 
observed in the lomefloxacin and enoxacin (Figure-1 Oa). 
The binding affinity of fluoroquinolone to double stranded DNA could be increased by 
the presence of gyrases [108] or by the presence of ATP. They directly interact with 
DNA in synergy with the gyrase enzyme [109-111]. 
Norfloxacin, one of the most potent DNA gyrase inhibitors of quinolone family does not 
bind directly to DNA gyrase but binds to DNA itself [112]. Further studies [113-114] 
showed that norfloxacin binds preferentially to the single stranded DNA. On the basis of 
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Figure-lOa. Absorption spectra of (a) LOM (4.5 x KT^ M) and (b) ENX (1.6 x W^ M) in 
10' M phosphate buffer at pH 7.4 in the presence of increasing amounts of 
CT-DNA. 
these findings, a cooperative qulnolone-DNA binding model for the inhibition of DNA 
gyrase has been proposed [115] in which norfloxacins were bound in the specific 
single-stranded DNA pocket which was induced by gyrase and were stabilized by the 
hydrogen bonding, n-n stacking of the norfloxacin rings, and the tail-to-tail hydrophobic 
interactions. 
The interaction of fluoroquinolones and DNA was further studied by fluorescence 
measurements. Fluorescence intensity at the isobestic points was markedly quenched 
(Figure-lOb) by the addition of polynucleotide [107]. 
450 500 
Wavelength / nm 
Figure-lOb. Fluorescence spectra ofenoxacin (1.6x 10'^ M) with increasing 
concentration of CT-DNA in the range 0-1.2 x Iff M 
Present work 
Dinuclear copper(II) complexes have been studied extensively owing to their relevance to 
metalloenzymes-dioxygen binding in hemocyanin, hemerythrin, tyrosinase, catechol 
oxidase and related blue copper proteins [116-120]. The design of these dinuclear 
complexes employs a s\nthetic strategy where different multidentate ligand systems are 
coordinated around vacant coordination sites on the metal ions [121-124]. The 
incorporation of a functionalh active ligand system, its denticity, chelate ring size, donor 
type, substituents on or near N-donors. influences the selectivity and M2-O2 structure 
reactivity [125-126]. Much emphasis has been given to the molecular framework by 
chosing an appropriate ligand system and pendant functional groups around the metal 
site. In this work, a biologically significant class of ligand p-diketone was chosen 
primarily as it exhibits versatile coordination ability and shows bidentate chelate 
formation [127], secondly, P-diketonate complexes have proved as efficient antitumor 
agents against various carcinoma [128]. The dinuclear copper complexes with two metal 
ions in close proximity have received great attention [129-131], due to their potential use 
as bimetallic catalysts modeling the enzyme activity. 
Novel dinuclear metaf complexes of the lieand [CialheOs] has been synthesized and 
characterized by spectroscopic techniques (i.r.. n.m.r, e.p.r.. u.v-visible spectroscopy 
and conductance measurements). Structure-activity relationship of the dinuclear complex 
was studied kinetically with the substrate ( pyrocatechol ) in the presence of O2 in DMF 
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at 25° C. Electrochemistry of the Cu(ll) model complex has been studied by cyclic 
voltammetry in DMSO + 0.4 M tetra-n butyl ammonium perchlorate (TBAP). 
Tertiary aminoalcohol, triethanolamine (TEOA) has attracted increasing interest [132] in 
metal coordination chemistry, and metal sites in biology. They have been particularly 
useful in deducing the structures of polynuclear metal complexes and the active sites of 
much larger metallobiomolecules [133]. A variety of their metal complexes have been 
synthesized with transition and representative metals [134-137]. 
Polynuclear/dinuclear architectural features generally require a space linker and this can 
be achieved by the presence of a proton-donating agents such as amino alcohol. The 
interactions between the two metal ions are able to control the stoichiometry and 
geometry of such dinuclear complexes [138]. 
In this series, we have synthesized the homodinuclear complexes of the transition metals, 
Cu(ll) and Ni(II), as potential structural and functional models for the active sites of 
catechol oxidase and characterized by various spectroscopic techniques, i.r., n.m.r., e.p.r.. 
u.v-visible and conductance measurements. The catecholase-mimetic activities of the 
dinuclear Cu(II) complex were investigated using u.v-vis spectroscopic studies in DMF 
solution. The electrochemical behavior of the Cu(II) complex has been studied by cyclic 
voltammetry (cv). 
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Fluoroquinolones (FQs), ciprofloxacin, sparfloxacin, lomefloxacin, norfloxacin, and 
ofloxacin are the broad-spectrum antibacterial agents. They have been used extensively 
for the treatment of many infections, viz. urinary infections [139], gonorrhoeae [140], 
tuberculosis [141], enteric infections, cholerae [142] and other infections of skin, lungs, 
bones and joints caused by susceptible bacteria [143]. The coordination chemistry of 
these drugs with metal ions of biological and pharmaceutical importance is of 
considerable interest. They have potential donor atoms available for moial binding 
through oxygen of carboxyl group, oxygen of pyridone moiety and nitrogen of piperazine 
ring [144]*such bindings are likely to leave some potential donor atoms free and these 
free donor atoms enhance the biological activity [145]. Although a number of compounds 
bearing CS: as a part of the complex has been prepared and characterized [146-147]. 
there are scant reports in the literature on the conversion of CST into organic derivatives 
e.g., alkyldithioformates, dithioacetals, etc. [148]. 
Chelates of organotin{lV) moieties with N, O and S donor ligands [149-150]. have 
received much attention during the last few years, due to their various industrial and 
agricultural applications [151], and also due to the ability of tin to afford stable bonds 
with carbons as well as with heteroatoms, a wide range of compounds found in organic 
synthesis and catalysis [152]. 
A novel class of metal based drugs of fluoroquinolone, ciprofloxacin-triphenyltin 
dithiocarbamate M(ll), where M(ll) = Cu(II), Ni(II) were synthesised and characterized 
by various spectroscopic techniques (i.r., n.m.r., e.p.r., uv-vis spectroscopy 
and conductance measurements). The antibacterial activity of complex was screened 
against E. coli. Interaction of [Cip(TpT)dtcCu(II)]. CI with calf thymus DNA was studied 
by uv-vis absorption spectroscopy and fluorescence measurements. The binding constant 
kb of the complex bound to calf thymus DNA was calculated. Viscometry and cyclic 
voltammetry were also performed to study the interaction of the complex with calf 
thymus DNA. 
Metals and their complexes have been used in the treatment of various ailments and 
diseases [153-155], selection of metal ions offers the possibility for the discovery of 
metallodrugs with novel mechanism of action [156]. Binding studies of small molecules 
to DNA are very important in the design of new therapeutic agents and DNA molecular 
probes [157]. Drug interacts with DNA and induce DNA damage, which leads to the 
blockage of cell division and eventually to cell death [158]. Sparfloxacin is widely used 
in the treatment of urinary tract infections because of its excellent activity against various 
bacteria, low frequency of adverse effects and good absorption. 
The complexes of sparfloxacin with Ni(II) and Cu(II) chloride were synthesized and 
characterized by various physico-chemical methods. Binding studies of the dinuclear 
Cu(II) complex with calf thymus DNA was studied by uv-vis spectroscopy, cyclic 
voltammetry, viscometry and fluorescence measurements. 
CHAPTER II 
EXPERIMENTAL 
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CHAPTER II 
EXPERIMENTAL METHODS 
The following techniques were employed to characterize the complexes and to illustrate 
their application, 
1. Infrared spectroscopy 
2. Ultra-violet and visible spectroscopy 
3. Nuclear magnetic resonance spectroscopy 
4. Electron paramagnetic resonance spectroscopy 
5. Molar conductance measurements 
6. Cyclic voltammetry 
7. Kinetic studies 
8. Viscometry 
9. Fluorescence measurements 
Infrared spectroscopy 
The infrared spectroscopy is a useful technique to characterize a compound. It results 
from transition between vibrational and rotational energy levels. I.r. region of the 
electromagnetic spectrum covers a wide range of wavelength from 200 to 
4000 cm". It has been found that in i.r. absorption, some of the vibrational frequencies 
are associated with specific groups of atoms and are the same irrespective of the 
molecules in which this group is present. These are called characteristic frequencies [159] 
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and their constancy results from the constancy of bond force constants from molecule to 
molecule. The important observation that the i.r. spectrum of a complex molecule 
consists of characteristic group frequencies which makes i.r. spectroscopy, an unique and 
powerful tool in structural analysis. 
Ultraviolet and visible spectroscopy 
When a molecule absorbs radiation, its energy is increased. This increased energy is 
equal to the energy of the photon expressed by the relation 
E = hv 
E = he / ?. 
where h is Planck's constant, v is the frequency, X is the wavelength of the radiation and 
c is the velocity of light. Most of the compounds absorb light in the spectral region 
between 200 and 1000 nm. These transitions correspond to the excitation of electrons of 
the molecules from ground state to higher electronic states. In a transition metal, all the 
five 'd' orbitals viz. d^ y, dyz, d^ z, dz^  and dx^ .y' are degenerate. However, in coordination 
compounds due to the presence of ligands, this degeneracy is destroyed and d orbital 
split into two groups tjg (dxy, dyz and dxz) and Cg (dz^  and dx^y") in an octahedral complex 
and t and e in a tetrahedral complex. The set of t2g orbitals goes below the original level 
of degenerate orbitals in octahedral complexes and the case is reversed in tetrahedral 
complexes (Figure-11). At energy higher than the ligand-field absorption bands. 
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Figurc-11(b). LiganJ-field splitting of tetrahedral complex. 
v\e commonly observe one or more very intense bands that go off scale unless log e is 
plotted. These normally are charge transfer bands, corresponding to electron transfer 
processes that might be lipand —>• metal (L—• M) or metal —• ligand (M—• L). 
M —• L transitions occur for motal-ion complexes that have filled, or nearly filled, t2g 
orbitals with ligands that have lou-lying empty orbitals. These empty orbitals are ligand 
7t* orbitals in complexes such as those of pyridine, bipyridine, 1,10-phenanthroline, CN', 
CO and NO. (Figure-12) shows overlap of a tig metal orbital and 7i* of CO. 
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Figure-12. Metal-carbon double bonding. 
The L —• M charge-transfer (C-T) spectra have been studied more thoroughly. The 
intense bands are for Laporte-allowed transitions commonly of the (ligand) p —• d 
(metal) type. The ionization energy for the ligand (or its ease of oxidation) as well as the 
oxidation state and electronic configuration of the metal (or its ease of reduction) 
determine the energy of the transition. No net oxidation-reduction usually occurs, 
because of the short lifetime of the excited state [160]. 
Nuclear magnetic resonance spectroscopy 
The nuclei of certain isotopes possess a mechanical spin or angular momentum. The 
n.m.r. spectroscopy is concerned with nuclei having spin quantum number I - 1/2, 
example of which include 'H, '^C, ^'P and " F . 
For a nucleus with 1 = 1/2, there are two values for the nuclear spin angular momentum 
quantum number mi = ±1/2 which are degenerate in the absence of a magnetic field. 
However, in the presence of the magnetic field, this degeneracy is destroyed such that the 
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positive value of mi corresponds to the lower energy state and negative value to higher 
energy state separated by AE. 
In an n.m.r. experiment, one applies strong homogeneous magnetic field causing the 
nuclei to precess. Radiation of energy comparable to AE is then imposed with radio 
frequency transmitter is equal to precision or Larmor frequency and the two are said to be 
in resonance. The energy can be transferred from the source to the sample. The n.m.r. 
signal is obtained when a nucleus is excited from low energy to high energy state. 
Electron spin resonance spectroscopy 
E.P.R spectroscopy [161] is the branch of absorption spectroscopy in which radiation 
having frequency in the microwave region is absorbed by paramagnetic energy levels of 
electrons with unpaired spins. The magnetic energy splitting is done by applying a static 
magnetic field. For an electron of spin S = 1/2, the spin angular momentum quantum 
number will have values of ms =+.1/2. In absence of magnetic field, the two values of 
ms i.e. +1/2 and -1/2 will give rise to a doubly degenerate spin energy state. If a magnetic 
field is applied, this degeneracy is lifted and leads to the non-degenerate energy levels. 
The low energy level will have the spin magnetic moment alligned with the field and 
correspond to the quantum number ms = -1/2. On the other hand, the high energy state 
will have the spin magnetic moment opposed to the field and correspond to the quantum 
number m, = +1/2. 
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Conductance measurements 
The conductivity measurements is one of the simplest and easily available techniques 
used to study the nature of complexes. It gives direct information regarding whether a 
given compound is ionic or covalent. For this purpose, the measurement of molar 
conductance (Am), which is related to the conductance value in the following manner is 
made. 
cell constant x conductance 
Am = 
concentration of solute expressed in mol cm'^  
Conventionally, solutions of 10'^  M strength are used for the conductance measurements. 
Molar conductance values of different types of electrolytes in a few solvents are given as, 
1:1 clectrolxtc has a value of 80-115 ohm' cm" mol' in methanol, 50-75 ohm"' cm^ mol' 
in dimethylformamide. 65-90 ohm'' cm^ moP' in dimethylsulphoxide and 35-45 ohm'' 
cm' mol' in ethanol [162-163]. Similarly a solution of 2:1 electrolyte has a value of 
160-220 ohm' cm^ mol' in methanol, 130-170 ohm'' cm* mol"' in dimethylformamide 
and 70-90 ohm' cni^  mol'' in ethanol. 
Cyclic voltammelr)' 
Cyclic voltammetry involves the measurement of current-voltage curves under diffusion 
controlled, mass transfer conditions at a stationary electrode, utilizing symmetrical 
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triangular scan rates ranging from a few millivolts per second to hundred volts per 
second. The triangle returns at the same speed and permits the display of a complete 
polarogram with cathodic (reduction) and anodic (oxidation) waveforms one above the 
other. Two seconds or less is required to record a complete polarogram [164]. 
Consider the reaction 
0 + ne • R (i) 
Assuming semi-infmite linear diffusion and a solution containing initially only species O. 
With the electron held at a potential Ei where no electrode reaction occur. The potential is 
swept linearly at v v/sec so that the potential at any time is 
E(t) = E,-vt 
or Epeak = E|/2- 0.0285 
The rate of electron transfer is so rapid at the electrode surface that species O and R 
immediately adjust to the ratio according to the Nernst equation which is as follows. 
Co(0,t)- Co*-[nFA(7rDo)"^]-' i(7c)(t-T)-"^  dx (ii) 
i = nFACo*(7rDoa)"^x(at) (iii) 
Redox (electron-transfer) reactions of metal complexes can be investigated by c>clic 
voltammograms. An electrode is immersed in a solution of the complex and voltage is 
swept while current flow is monitored. No current flows until oxidation or reduction 
occurs. After the voltage is swept over a set range in one direction, the direction is 
reversed and swept back to the original potential. The cycle may be repeated as often as 
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desired. (Figure-13) shows the cyclic voltammograms (CV) for a reversible one-electron 
redox reaction such as, 
CpFe(CO)LMe • CpFe(CO)LMe* + e" 
Sweeping the potential in an increasing direction oxidize the complex as the anodic 
current ia flows; reversible reduction of CpFe(CO)LMe'^  generates cathodic current ic on 
the reverse sweep. The magnitude of the current is proportional to the concentration of 
the species being oxidized or reduced. 
The measured parameters of interest on these cyclic voltammograms are ipa/ipc the ratio of 
peak currents and Epa - Epc the separation of peak potentials. For a Nernstian wave with 
stable product, the ratio ipa/ipc = I regardless of scan rate, E;^  and diffusion coefficient, 
when ipa is measured from the decaying current as a base line. The difference between Epa 
and Epc(AEp) is a useful diagnostic test of a Nernstian reaction. Although AEpis slightly a 
function of E\, it is always close to 2.3RT/ nF. 
Figu re-13. (a) Cyclic potential sweep (b) Resulting cyclic voltammogram 
The technique yields information about reaction reversibiUties and also offers a rapid 
means of analysis for suitable systems. The method is particularly valuable to study 
metallo-intercalation and interaction of metal ions to DNA as it provides a useful 
compliment to other methods of investigation, such as UVA^is spectroscopy. Cyclic 
voltammetric measurements were accomplished with CH instrument electrochemical 
analyzer. Supporting electrolyte for the experiments was 0.4M KNO3/O.4 M n-Bu4NC104 
A three electrode configuration was used, comprising of a platinum disk as working 
electrode, platinum wire counter electrode and Ag/AgCl as reference electrode. All 
solutions were deoxygenated via. purging with N2 at room temperature. 
Kinetic studies 
In a closed constant volume system, the rate of a chemical reaction is defined as the rate 
of change with time of the concentration of any of the reactants and products. The 
concentration can be expressed in any units of quantity per unit volume e.g. moles per 
liter, moles per cubic centimeter. The rate will be defined as positive quantity regardless 
of the component whose concentration change is measured. 
Consider the general chemical reaction 
aA + bB • cC + dD 
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The rate can be expressed as 
-dA , :dB_ , .dC_ or dP 
dt dt dt dt 
where A, B, C and D designate the concentration in arbitrary units. 
The rate of a chemical reaction is not measured directly instead the concentration of one 
of the reactants or products is determined as a function of time. A common procedure for 
determining the reaction order is to compare the experimental results with integrated rate 
equations for reactions of different orders. For a first order rale equation, integrating by 
separate variables using integration limits such that at t = 0, c = co and at t = t, c = c. 
[165]. 
-dc/dt = kc 
or In (CQ/C) = kt 
If the reaction is first order, a plot of In c or log c versus time should give a straight line 
with a slope of-k or -k/2.303 respectively. The dependent variable chosen is the decrease 
in concentration of reactant. If this variable is designated as x and Co is the initial 
concentration, 
dx/dt = k(co-x) 
lnco/(co-x) = kt 
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If however, the conditions for a given reaction are such that one or more of concentration 
factors are constant or nearly constant during a reaction, these factors are included in the 
constant k. In this case, the reaction is said to be of pseudo-nth order or kinetically 
nth order where n is the sum of the exponents of those concentration factors which 
time 
Figure-14. 
alter the reaction [166]. This situation is true for catalytic reactions where the 
concentration of catalysts remains constant throughout the reaction, if one reactant is in 
large excess over another so that during the reaction there is only a small percentage 
change in the concentration of the former reactant. 
The kinetics of the dinuclear Copper(Il) complexes were performed with 
pyrocatechol (substrate) in the presence of O2 in DMF at 25° C, by using the experimental 
procedure reported earlier [167]. The reactions of the complex with varying 
concentrations of pyrocatechol were progressively monitored by the appearance of 
absorption maximum of the substituted quinone product (X^ ax = 25,000 cm'') using a 
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systronic 119 spectrophotometer and USB 2000 Ocean optics spectrometer. The kinetic 
parameters Vmax, KM were determined by using Michaelis-Menten method. 
Another set of experiment involving interaction of the complexes with calf thymus DNA 
were conducted in buffer (9.2 pH), doubly distilled water and tris-HCl buffer (7.5 pH), 
respectively. The intrinsic binding constant, Kb of the complexes to calf thymus DNA 
were determined from Equation (3) [168a] through a plot of [DNA]/8a-Ef versus [DNA]. 
[DNA] = [DNA] ^ -J (3) 
£a-8f Sb-Ef Kb(Eb-ef) 
Where [DNA] represents the concentration of DNA, Eg, Ef and Eb are respectively the 
apparent extinction coefficient (Aobs /[M]), the extinction coefficient for free metal (M) 
complex and the extinction coefficient for free metal (M) complex in the fully bound 
form. In plots of [DNA]/ Sa-Ef versus [DNA], Kb is given by the ratio of slope to intercept. 
Calf thymus DNA was obtained from Sigma. The stock solution of calf thymus DNA was 
prepared by dissolving it in 10 mM tris(hydroxymethyl)aminomethane hydrochloride 
(tris-HCl) buffer at pH 7.5 and dialyzing exhaustively against the same buffer for 48 h. 
The solution gave a ratio o f » 1 . 8 at A260/A280, indicating that calf thymus DNA was free 
from protein [169]. The concentration of calf thymus DNA was determined 
spectrophotomctrically by monitoring the u.v. absorbance at 260 nm using E260 = 6600 
cm' . The slock solution was stored at -20 °C. 
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Viscosity Measurements 
Viscosity measurements were carried out using Ostwaid's viscometer at 29 ± 0.01°C. 
Flow time was measured with a digital stop-watch. Each sample was measured four times 
and an average flow time was calculated. Data were presented as (r|/r| o) versus binding 
ratio ([Cu]/[DNA]), where T] is a viscosity of DNA in the presence of complex and r\o 
is the viscosity of DNA alone. Viscosity values were calculated from the 
observed flow time of DNA containing solution (t >100s) corrected for the flow time of 
buffer alone (to), ii = t- to [ 170] 
Fluorescence measurements 
Fluorescence measurements were carried out using shimadzu spectrofluorometer, model 
RF-540 equipped with a data recorder, DR-3. The equilibrium constant was calculated by 
Stern-Volmer equation [171], 
lo/I = 1 + kb[CT-DNA] 
Where kb is the Stern-Volmer constant and loand I are the fluorescence intensity in the 
absence and presence of CT-DNA. IQ/I is plotted against the DNA concentration, the 
Stern-Volmer constant which is equivalent to the equilibrium constant for the complex 
formation was calculated from the slope. 
Biological Activity 
Antibacterial Activity 
The bacterial activity of the complexes [C36H32N3F03S2Sn] and [C36H35N3F05S2SnCu]. 
CI in terms of their growth inhibitory property on specific known bacterial culture was 
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evaluated by disc diffusion technique [172] using Mueller-hjnton agar as the medium. 
E.coli, a gram-negative bacteria was used as test organism. A solution of each test 
compound was prepared in methanol and further dilutions were made with the same 
solvent. All the dilutions and stock solution were sterilized by filtration.^' The 
concentrations tested were 50, 12.5 and 3.1 fig ml'' of the compounds, the respective 
metal complexes [C36H32N3F03S2Sn] and [C36H35N3F05S2SnCu].CI were dissolved in 
methanol and DMF. Holes of diameter 4 mm were dug into the agar plates with a sterile 
borer and filled with different dilutions of the drug. The plates were incubated at 37 °C 
for 24 h. The inhibition of growth of the gram-negative organism produced by various 
concentrations of test compounds were compared under identical conditions with the 
inhibition of growth of the same organism by ciprofloxacin. Zone of inhibition is 
measured and recorded in millimeters. 
CHAPTER III 
Synthesis of new dinuclear dicopper(II) and dinickel(II) 
complexes; Kinetics of catechol oxidase and electrochemistry of 
dicopper(II) complex. 
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CHAPTER III 
Experimental 
Salicylaldehyde (Lancaster), acetylacetone (S.d.fme-Chem Ltd.), 1,2-dibromoethane 
(Merck), CuCh and NiCh (anhydrous) \sere used. Microanalysis of the complex was 
obtained on a Carlo Erba Analyzer Model 1106. I.r. spectra (400-4000 cm"') were 
recorded on a Carl-Ziess Specord M-8() Spectrophotometer in Nujol mull. The electronic 
spectra were recorded on a S>stronic 1 19 UV-visible spectrophotometer. The n.m.r. 
spectra weie recorded on an am.xoOO instrument. The e.p.r spectrum was run on an 
Electron Spin Resonance Spectrometer. Molar conductance measurements were made on 
a CM 180 Elico Conductivity bridge. 
Cyclic voltammetry measurements were carried out on a CH instrument electrochemical 
analyzer. High purity DMSO solvent was employed for the cyclic voltammetric studies 
with 0.4 M n-Bu4NC104 (TBAP) as a supporting electrolyte. The kinetics of the 
dinuclear Copper(ll) complex with varying concentrations of pyrocatechol were 
progressively monitored by uv-vis spectroscopy. 
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Synthesis of Ligands L, 2-hydroxy benz}lidene fi-diketone and L', ethylenefOO'-bis 
sa/icy/idene fi-diketone] 
Salicylaldehyde (5 cm\ 0.047 mol) and acetylacetone (5 cm\ 0.040 mol) were mixed in 
equimolar ratio (1:1) and the mixture was refluxed for ca. 48 h. A yellow compound was 
isolated by adding MeOH (20 cm )^ to the reaction mixture. The product [L] was washed 
with hexane and dried in vacuo. 
To a solution of compound [L] (3.00 g.v 0.015 mol) in DMF(50 cm^) was added 
1,2-dibromoethane (2.72 cm ,^ 0.031 mol) in a 2:1 molar ratio and resulting solution was 
boiled under reflux for ca. 24 h. A dark brown precipitate [L'] appeared on adding 
MeOH to the reaction mixture which was filtered , washed thoroughly with hexane and 
dried in vacuo. Physical data are presented in (Table I). 
Synthesis of bisfOO'-bis salicylidene fi-diketone copper(II)] chloride and bisfOO'-bis 
salicylidene fl-diketone nickel(II)] chloride complexes. 
To a solution of the Ligand [L'] (0.434 g, 0.001 mol) in DMF (3 cm^) was added CuClj 
(0.133 g, 0.001 mol) in 1:1 molar ratio and the mixture was boiled under reflux for 
ca. 14 h. The red precipitate thus obtained, was filtered, washed thoroughly with hexane 
and dried in vacuo. 
NiCb (0.128 g, 0.001 mol) was added to the ligand [L'] (0.434 g, 0.001 mol) in DMF 
(3 cm^) in 1:1 molar ratio and the mixture was boiled under reflux for ca. 14 h. A brown 
colored precipitate was obtained, which was filtered washed thoroughly with hexane and 
dried in vacuo. The synthesis procedure is outlined in (Scheme-1). 
39 
H^C 
Clio 
\ 
+ 
/ 
H,C 
C = 0 
-H7O 
.C=0 
H3C 
/ 
a." ,0—CH, CH2 O. H \ , n 
"'VY" "V Y" 
° O (f) ° ° 
MCI. 
OH 
.H 
H,C^ ^ C ^ /CH3 
o o 
C2H4Br2 
-2HBr 
(L) 
O CH, CH, O. 
0:.- -c 
i II 
H3C., ^ l ^ /CH3 H3C C ^ CH3 
C C II M 
ON / O 
O^ ^ O 
M 
9" "--o 
-C^ X, 
^' '-" "C- \ H , H,C/ V -CH3 
OCN-
' ^ , 
H' 
O CH2 CH2 O .CL 
Scheme-l: M = Ni(ll), Cu(ll) 
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Results and discussion 
I.r. spectra 
The i.r. spectrum of the ligand, L (Table 2) derived from salicylaldehyde and 
acetylacetone, exhibits a characteristic band at 3048 cm'' due to the v(OH) vibration 
[173]. However, the v(OH) band disappears in the ligand, L', confirming the removal of 
hydrogen as HBr and dimerisation of L to L' gives ethylene (OO'-bis-salicylidene-P-
diketone). The formation of L' is further supported by n.m.r. spectral data which shows a 
prominent 6CH2 signal at 3.6 ppm, though, it is difficult to distinguish the CH2 vibration 
in i.r. spectrum which appears coupled with the v(C-C) band. The characteristic 
absorption bands due to condensed acetylacetone attributed to v(C=0), v(C=C) and 
v(C-H), appear in the 1628-1665 cm"' regions, 1485 and 2928 cm"' regions respectively in 
the ligand L, L' and the complexes [174]. However, the i.r. spectra of the complexes 
exhibits a shift in v(C=0) band (ca. 37 cm"') which indicates coordination of the metal 
ion through the -C=0 group of L'. This is further authenticated by far i.r. spectra which 
exhibit new bands attributed to v(Cu-O) and v(Ni-0) at 500 cm"' and 493 cm"' 
respectively [175]. The I.r. spectral data are in good agreement with the proposed 
structure for the complexes. 
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Electronic spectra 
The electronic spectrum of the dinuclear copper(II) complex exhibits an intense LMCT 
band at 22,026 cm' ' , a shoulder at 18,587 cm'" and a broad band in the visible region 
which is consistent with the presence of copper(Il) ion in square-planar environment in 
which the anions or solvent may occupy the axial positions. However, the featureless 
nature of the spectra results in being of little use for the assignment of ligand Held 
transitions for determining coordination geometries [176-180]. 
The spectrum of the nickel(ll) complex shows a broad band at 22,831 cm" which may be 
assigned to the overlap of B|g • 'B:g and 'B|g • 'Eg transitions, indicating 
square-planar geometry around the nickel(ll) ion. 
E.p.r. spectrum. 
The e.p.r spectrum of the dinuclear copper(ll) complex reveals g value of 2.002 at the 
liquid nitrogen temperature LNT (77 K) (Figure-15). The gn value (2.18) and gi value is 
(2.05) with two humps at 3.577 and 3.056 (high field) due to partial interaction of 
Cu-Cu ions [181]. The g values are related to the axial symmetry parameter, G, by the 
expression G = (gn . 2)/(gi . 2)- The G values measure the extent of the exchange 
interaction between the copper centers in the polycrystalline solid. In the present case. 
G = 3.81, which indicates the presence of partial exchange interaction in the complex. 
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Figure-15. The e.p.r. spectrum of (he bis[00'-bis salicylidene fi-diketone 
copper(ll)] chloride at INT (17 "K). 
N.m.r. studies 
The coordinating mode of ligand and complex are further confirmed by recording H and 
'"C n.m.r spectra. Assignments of the relevant peaks recorded for the ligand and complex 
are presented in (Table 3 and 4). The multiplets in the range 7.0-7.5 ppm and 6.9 ppm 
have been observed corresponding to the aromatic protons of the ligand and complex 
respectively. The absence of-OH proton signal in the 'H N M R spectra of L' indicates 
the deprctonation of the -OH group and a signal at 3.6 and 2.9 ppm has been observed in 
ligand L' and the complex which is assigned to the -CHi- protons [182 ]. -CH3- protons 
have been observed in the range 0.8-1.7 ppm. 
'^ C NMR of the ligand and complex show a band in the range 126.0-128.9 ppm 
assignable to the aromatic carbons. A band in the 150.0 and 160.2 ppm range due to 
(C=0) carbon has been observed in the ligand and complex. Methyl carbons are observed 
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in the range 25.3-28.2 ppm. Presence of -CH2- carbons in the range 39.6, 37.3 ppm in 
ligand L' and complex [C52H520i2Ni2].Cl4 indicates the bridging by -CH2- group of 
1,2-dibromoethane. 
Electrochemistry 
The electrochemistry of the model complex, bis[00'-bis-salicylidene-P-diketone 
copper(Il)] chloride, has been studied by cyclic voltammetry in DMSO + 0.4 M tetra-n 
butyl ammonium perchlorate (TBAP). The cyclic voltammogram recorded in DMSO 
solution of the complex shows one electron per copper attributed to the quasi-reversible 
signal Cu"Cu" -> Cu" Cu'and Cu" Cu'-> Cu' Cu'; the free dinuclear Copper(II) complex 
exhibits sharp oxidation and reduction peaks E1/2 at -0.585 V and -0.628 V which is 
followed by an irreversible cathodic response at E1/2 = 0.538 V (Figure-16). After 
bubbling O2 gas into the solution of dinuclear copper complex , a new cathodic peak 
emerges at E1/2 -1.390 which authenticates the binding of O2 to the dinuclear copper(II) 
complex and formation of a Cu — O2 — Cu Complex (Figure-17). 
The cyclic voltammetry of catechol oxidase activity has been measured in a solution, 
saturated with O2, the oxidation reduction peak being tentatively assigned to one electron 
per Cu"Cu" — Cju"Cu' -> Cu'Cu'. The c.v. of the catalytic reaction reveals the cathodic 
peak at E1/2 - 0.620 V, anodic oxidation - 0.870 V and AE1/2 (0.25 V) is observed 
(Figure-18). The catalytic reaction has been observed with respect to time, and different 
c.v. scans have been done to observe the catechol oxidase activity of the dinuclear 
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complex.The changes in c.v. scan on completion of catechol oxidase activity of the 
complex are displayed (Figure- 19). The quasireversible couple recorded in Figure-18 
has diminished completely and only some irreversible peaks retain E1/2 -0.607 V, 
-0.849 V which are commensurate with the oxidation of pyrocatechol and the formation 
of o-benzoquinone. The derivative curve of cyclic voltammogram gives a very clear 
indication about the catalytic behavior of the dinuclear complex (Figure-20). 
c 
(-
0 -0.4 -0.8 -1.2 
Po ten t ia l /V 
1.6 
Figure-16. Cyclic voltammogram of the free dinuclear copper(II) complex in DMSO at 
room temperature at a scan rate ofO. 1 Vs''. 
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Potential / V 
Figiirc-17. Cyclic vollammogram of the dinuclear copper(II) complex in DMSO after 
hiihhliiig O: f^as al room temperature. 
0.8 0.4 0 -0.4 -0.8 -1.2 -1.6 -2.0 
Potent ia l /V 
Figure-18. Cyclic vollammogram of dinuclear copper (II) complex in DMSO (saturated 
with O2) in presence of pyrocatechol recorded al the initial stage at room 
temperature, c.v. change reveals the catalytic oxidation of pyrocatechol to the 
formation ofc/iiinone. 
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c 
a; 
0 -0.i -0.8 -1.2 -1.5 
Potentiol/V 
Figure-19. Cyclic vollammogram of dinuclear copper(II) complex in DMSO ( saliirulecl 
with O2 ) after the completion of the catalytic reaction with pyrocatechol. 
Pyrocatechol has been converted to o-benzoquinone completely by the 
dinuclear copper(II) complex. 
0 -0.4 -03 -1.2 
Potentiol /V 
Figure-20. The derivative curve of cyclic voltammogram of dinuclear copper(Il) 
complex in DMSO (saturated with Oj) in presence of pyrocatechol (Figure-
20a.J. The figure reveals the change in c.v. after the catalytic oxidation. 
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Kinetic studies for catecholase activity 
The catecholase activity of the dinuclear copper(n) complex was followed 
spectrophotometrically by the catalytic oxidation of pyrocatechol. The experiments were 
carried out in DMF saturated with molecular oxygen. A solution of catechol of 
concentration (4x10"^  mol dm"^ ) in this solvent displays no bands in the 28,571-
14,285 cm'' region. A solution of the dinuclear copper(II) complex, bis[00'-bis-
salicylidene-P-diketone copper(ll)] chloride (concentration 1 x 10' mol dm') was 
prepared in DMF. To a (100 cm )^ catechol solution of varying concentration (3-6 xlO' 
mol dm''') in different sets of experiments in a quartz cuvette was added (100 cm ) of 
copper(ll) complex and (100 cm )^ of tris-HCl buffer and (3.7 cm^) DMF saturated with 
molecular O2. The pH 8.0 of the solution was maintained throughout the experiment by 
adding tris- HCl buffer. This is the most favorable pH for the catalytic activity as earlier 
reports on pH dependence studies reveal that no catalytic activity is observed in similar 
complexes below the pH range 7.0-7.5 [167].The absorption spectrum in the 28,571-
11,111 cm'' region was immediately scanned (Figure-21), Scanning was continued after 
5 min. and the reaction was completed after 25 min. (Figure-22). The spectrum 
drastically altered during the course of reaction. Initially a d-d band appeared at 22,026 
cm' which disappears completely with emergence of a new band simultaneously at 
25,000 cm'' assigned to the formation of o-benzoquinone due to oxidation of 
pyrocatechol [183-184]. Oxygen participates directly in the catalytic cycle of enzyme 
48 
.11 o.,lI 
activity and reoxidising dinuclear copper complex L-Cu -Cu -L back to active L-Cu -Cu -L 
species (Scheme-2). 
Saturation kinetics were performed for initial rates versus the concentration of dinuclear 
complex. An analysis of the data was done on Michaelis-Menten Model. The parameters 
Vmax, KM were determined from Lineweaver-Burk plots (Figure-23) and a value of 
Vmax (3 X 10"' MS"') and KM (2.2 x 10"^  mM) for the dinuclear complex was obtained. 
'L-<:u'L<:u'Lu. ^ y ^ 
Scheme 2 
10 15 
Time (min.) 
Figure-21. Representative curves of enzyme kinetics of dinuclear copper (II) complex 
with pyrocatechol. The reactions were performed in DMF saturated with O2, 
Tris HCl buffer (pH 8.0) and pyrocatechol of different concentrations 
(3-6x10'^ mol dm'^). 
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Figure-22. Ab.sorplion spectra ofCu(II) complex in DMFsaturated with O2 . Tris HCI 
buffer andpyrocatechol showing increase in absorbance with respect to time. 
0.3 
2: 0.2 -
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> 
0.0 .003 .004 .005 -006 
Concentra t ionof thesubst ro te(PyrocQtechoUM 
Figure-23. Dependence of the rate of reaction on the concentrations of the (substrate) 
pyrocatechol catalysed by dicopper(II) complex. Kinetic parameters V„,ax and 
KM for the oxidation reaction of pyrocatechol were calculated. 
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The complex exhibits the identical turnover rate (ca. 24 h'') and with constant KM value 
which is in good agreement with the second-order rate constant. The reaction sequence is 
as follows. 
Dinuclear Cu(lI) complex + catechol -. Cu-Catechol complex 
E + S ES 
K+2 
*. dinuclear copper (II) complex + quinone 
E + P 
The rate law which holds good for the above reaction sequence is 
V = d[P]/dt - K+:[ES] = K+2[Eo][S]/[S] + KM 
where (V) is the rate of reaction at which the product is formed, 
or simplifying 
V = V,„a,[S]/[S] + KM 
Where S is the concentration of substrate and Vmax is the maximum rate of reaction, 
which occurs when the enzyme is completely saturated with substrate. 
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CHAPTER IV 
Synthesis of OjO-ethylene bridged bis-metallated macrocycles; 
Selective enzyme models for catecholase activity. 
CHAPTER IV 
Experimental 
Ethanolamine, ibmnaldehyde, l,2-dibiomoethanc(Merck), C11CI2.2I I2O, NiCU.fill:^ 
(BDII) and tricthylenelclramine (Fliika) were used. Microanalysis ofthc complexes were 
carried out on a Carlo Erba analyzer model 1108. Molar conduclance was measured al 
room temperature on a Digisun electronic conductivity bridge. Infrared spectra 
(400-4000 cm'') were recorded on a Shimadzu 8201 PC spectrophotometer in Nujol mull. 
The electronic spectra were recorded on a USB 2000 Ocean Optics spectrometer, 'll and 
'•'C n.m.r. spectra were recorded on a Bruker DRX-300 spectrometer. The e.p.r. spectra 
was run on a Varian El 12. High purity, H20/MeOH (95:5) solvent uas employed lor tlie 
cyclic voltammclric studies. Kinetic cxperimenls of the dinuclcar copper(ll) complex 
were performed at room temperature by using USB 2000 Ocean Optics spectrometer at 
varying concentrations of pyrocatechol. 
Synthesis of lC,„H2sI^$OCu]. (€104)2 
(2.00 g. 0.011 mo!) of CuCh. 2H2O was dissolved in 5 cm^ of methanol. To this solution 
was added triethylenetetramine (1.63 cm ,^ 0.011 mol), ethanolamine (1.65 cm\ 0 011 
mol) and formaldehyde (0.94 cm\ 0.022 mol) in a 1:1:1:2 molar ratio. The resuliinjj 
green colored mixture was refluxed for ca. 24 h. The solution was cooled at room 
temperature and nitercd. Excess of perchloric acid was added to the fillerate and the 
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niixtiiie was kept in refrigerator. The green crystals which separated out, were washed 
thoroughly with methanol and dried in vacuo. 
Synthesis of/C,„H2s!^sONiJ. (ClOdi 
To a solution of NiCh 6H2O (2.00 g, 0.008 mol) in MeOH (5 cm^) was added 
tricthylcnetelramine (1.25 c m , 0.008 mol), ethanolamine (1.20 cm' , 0.008 mol) and 
formaldehyde (0.688 c m \ 0.016 mol) in a 1:1:1:2 molar ratio and the reaction mixture 
was rclluxcd for 24 h. The mixture was cooled at room temperature and filtered. To the 
filtcralc, excess of perchloric acid was added and kept in refrigerator. The yeUow crystals 
appeared, which were filtered, washed thoroughly with methanol and dried in vacuo. 
Synlhesis of IC2:11^2^ 10O2CU2I(CIO^)^ 
The mononuclear complex [CioH25N50Cu].(CI04)2 (1.00 g, 0.004 mol) dissolved in DM1' 
(18 cm') by heating on water bath. To this solution was added 1,2-dibromoethane (0.171 
cm^. 0.002 mol) in 2:1 molar ratio and the resulting mixture was retluxed for 5 h until a 
dark brown solution resulted. The solution was reduced to half the volume and left 
overnight in refrigerator. A dark brown colored complex appeared, which was filtered, 
washed with hexanc and dried in vacuo. 
Synthesis of jC 22Ih:^ 11^:^12}-(CIO4), 
To a M.luii.Mi of lC,oH25N50Nil.(CI04)2 (1.00 g, 0.004 mol) in DMF was added 
l,2-dibrc)mi)clhane (0.171 cm", 0.002 mol) in 2:1 molar ratio and boiled under refiux for 
5 h. The resulting solution was concentrated to half its volume and kept in refrigerator. A 
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light brown complex is isolated, which was filtered, washed with hexanc and dried in 
vacuo. The synthesis procedure is outlined in (Scheme 3). 
Results and discussion 
Dinuclcar complexes have been synthesized by the reaction of mononuclear complexes 
with K2-dibromoethane in 2:1 molar ratio. The elemental analysis and other physical 
data arc presented in (Table 5). The conductance values (lO"'^  M) in DM1- indicate thai tiic 
mononuclear and dinuclear complexes are 2:1 and 4:1 electrol>les, respectively. 
I.r spectra 
The i.r spectra of the mononuclear and dinuclear complexes are displayed in (Table 6). 
The mononuclear complexes [CinH25N50Cu].(CI04)2 and [CioH25N50Ni].(C104)2 exhibit 
characteristic v(N-H) of the coordinated secondary amines in the range of 3200 to 3210 
cm"' 1185] and show 0-H stretching vibration of the pendant arm at 3400 cm'' [I86J. The 
v(Cll2) vvas observed in the range of 2926-2931 cm'' [187]. The appearance of broad 
absorption at 1113 cm"' indicates the crystallization of ionic perchlorates [188]. 
The dinuclear complexes show i.r bands similar to the mononuclear complexes except 
that there is disappearance of v(O-H) at 3400 cm''. This clearly demonstrates the 
formation of ethylene bridge through alcoholic 0-H which is further authenticated by the 
presence of v(C-O) at 1242 cm'' in the dinuclear complexes [189]. The formation of 
dinuclear complexes is further supported by 'H n.m.r and '^ C n.m.r data. The v(M-N), 
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v(N-ll) and v(CI04) appears at 495-498 cm-', 3222-3225 cm"' and 1113-1 120 cm' 
respectively [190-192]. 
E.p.r spectra 
The solid state e.p.r spectrum of the mononuclear copper(ll) complex at liquid nitrogen 
temperature LNT (77 K) (Figure-24) exhibits a large isotropic signal centered at 
g = 2.057. corresponding to the square-planar Cu(II) ion [193]. In contrast, the e.p.r. 
spectrum of dinuclear Cu(ll) complex was found to be anisotropic with two g values 
(Figure-25). The parameters gn = 2.094, gi = 2.025 and gav = 2.048 were computed 
from the spectrum using TCNE free radicle as 'g' marker. The existence of gii>gi 
suggests that d "^-^ ' is the ground state for the d'^ [Cu**] configuration i.e (Cg)'' {a\^)' 
(b:c)"(b|j;)' suggesting square-planar geometry around Cu(ll) centers [194-195]. 
In addition . there is exchange coupling interaction between two copper centers explained 
by Hathaway expression G = (gii-2)/gi-2). According to Hathaway, if the value of G is 
greater than four, the exchange interaction is negligible, whereas when the value of G is 
less than four, a considerable interaction is indicated in the solid complex. For the 
dinuclear copper(ll) complex, the value of G was found to be 3.76 indicating the 
exchange interaction between two copper centers. 
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Figurc-25. The e.p.r spectrum of complex [C22Hs2Nio02Cu2].(Cl04)^ cil LNT (77 K). 
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Electronic spectra 
The electronic spectra of mononuclear complex [CioH25N50Cu].(CI04): displays a broiiJ 
d-d band at 15,151 cm"'due to the transition "Big • " A i g which commensuralcs with 
the square-planar geometry around Cu(Il) metal ion [196,197]. The electronic spoclruiii 
o f dinuclear complex [C22l-l52N|o02Cu2].(CI04)4 in DMF is dominated by an intense b;nul 
at 14.705 cm"' suggesting square-planar geometry around Cu(Il) ion. A single baiul 
centered at 22,271 cm"' in the electronic spectrum of the complex [Cml bsN^ONi^C'IOi), 
indicate .square-planar geometry around Ni(II) ion [198]. The spectrum of diiiuclc;ir 
nickel(Ii) complex exhibits a band at 21,739 cm"' which is assigned to ' A I ^ ~^ 'B^J 
transition, characteristic of square-planar geometry around the nickel(ll) ion. 
N.m.r spectra 
' H and '^C n.m.r spectra of the mononuclear [CioH25N50Ni].(€104)2 aiid dinucle;ir 
[C22ll52Ni()02Ni2].(CI04)4 complcx were recorded in DMSO-d(, and compavcd 
(Table 7 and 8). ' H n.m.r spectra of mononuclear Ni(! I) complex exhibits signals in the 
range 8 2.98-3.01, 8 2.08-2.10 (dd,4H), 8 2.40-2.89 (m,12H) due to NII-CII2-N. 
CH2-CH2-N and HN-CH2-CH2-NH respectively [199]. Two more signals appear at 3.93 
and 7.67 ppm due to CH2OH and NH protons [200]. The n.m.r spectra of dinuclear 
complex [C22H52Nio02Ni2].(C104)4 reveals no change in the above signals, except 
disappearance of the signal of OH at 3.93 ppm and new signal appear in the range o!" 
8 3.46-3.87 (m,4H) due to O-CH2-CH2-O confirming the dinuclear 
complex formation [201]. 
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' C n.m.r spectra of mononuclear Ni( l l ) complex exhibit C-C, C-N, C-OII and - C l h 
signals at 37.90-40.34, 42.76, 150 and 35.3-36.61 respectively [202]. The " C carbon 
signals appear in the same range in dinuclear complex along with new signal at 
68-70 ppni due to O-CH2-CH2-O which further authenticate the formation o f - C I N-CI b-
bridged dinuclear Ni( i l ) complex [203]. 
Electrochemical studies 
The electrochemical behavior of the dinuclear complex [C22H52N|o02Cu2].(CI04)4 ha.s 
been studied by cyclic voltammetry. The cyclic voltammogram of the free dinuclear 
Cu(ll) complex in II2O/DMF (95:5) at a scan rate of 0.IVs"' reveal one electron 
quasircvcrsiblc wave attributed to redox couple Cu'VCu' with formal electrode potential 
E|/2 - -0.565V (E|K. = -0.620V, Epa = -0.510V), the ratio of anodic to calhodic peak 
currents ip;,/ipc = 0.814 and AEp = 0.110 V which is larger than Nernstian value observed 
for one electron transfer (Figure-26). After passing molecular oxygen to the solution of 
the complex, the cyclic voltammetric behavior differs considerably from the free complex 
as the formal electrode potential Ei/2= -0.593 V (Epc = -0.655 V and Ep;, = -0.531 V). 
ipa/i|x= 2.93 and AEp= 0.124 V (Figure-27). The shift in formal electrode potential Ei/2as 
well as cathodic and anodic peak potentials indicate the binding of oxygen to the 
dinuclear Cu(l l) complex. The redox behavior for the catechol cleaving dioxygenase 
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3 
u 
Potential / V 
Figure-26. Cyclic voltammogram of dinuclear copper(II) complex 
[C22Hs2NinO:Cu2]. (€104)4 (1 x W M) in DMF at a scan rate ofO. 1 Vs -I 
0 -0.4 -«« -1.2 
Potential / V 
Figure-27. Cyclic voltammogram of dinuclear copper(II) complex in DMF after passing 
O2 gas. 
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activity of the present complex towards pyrocatechol was examined in presence of 
molecular oxygen at a scan rate of 0.1 Vs"' (Figiire-28). On addition of pyrocatechol to 
the complex solution in presence of O2, the cyclic voltammetric results of the catalytic 
reaction reflects the quasi-reversible wave for the one electron transfer Cu'VCu' couple 
with Epc = -0.655 V, Epa = -0.501 V, E1/2 = -0.57 V, with emergence of a new cathodic 
peak at 0.015 V. The cyclic voltammogram for the catecholase activity of the dicopper 
complex shows a shift of 0.001, 0.006 and 0.017 V in the cathodic and anodic peaks after 
sometime (Figure-29). 
1.2 0,8 0.4 0 
Potential / V 
-0.4 -0.8 -1.2 
Figure-28. Cyclic voltammogram ofdinuclear copper(II) complex taken initially in the 
presence of pyrocatechol. 
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Figure-29. Cyclic voUammogram ofdinuclear copper(II) complex after the complete 
conversion ofpyrocatechol into o-benzoquinone by the dinuclear copper(II) 
complex. 
Kinetic studies for catecholase mimetic activities 
The catalytic oxidation ofpyrocatechol by the model complex [C22H52N10O2CU2] .(€104)4 
was carried out spectrophotometrically. Nishida and co-workers [204] have found that 
dinuclear copper(II) complexes exhibit a high catalytic activity in comparison to 
mononuclear complexes and proposed that a determining factor is the presence of two 
metal centers located in close proximity to facilitate the binding of the two oxygen atoms 
of the catechol prior to the electron transfer [205]. Catalytic studies were performed in 
DMF solution owing to the good solubility of the dinuclear copper complex as well as 
substrate in DMF. To a (100 cm^) solution of [C22H52N10O2CU2]. (CI04)4 (concentration 
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1x10' mol dm') was added (100 cm) catechol solution of varying concentration 
(3 xlO'\ 3.5 x\0'\ 4 x\0-\ 4.5 xlO•^ 5 xlO"^ 5.5 xlO"^  ,6 xlO"^  mol dm'^), (100 cm^) of 
tris-HCl buffer pH 8.0 and (3.7 cm )^ of DMF saturated with molecular O2. The course of 
the reaction was followed by Uv-vis spectroscopy (Figure-30). The absorption spectra of 
the original solution in absence of pyrocatechol recorded two absorption maxima at 
35.971 and 14,705 cm'' which were attributed to CT bands and d-d transition of the metal 
ion respectively. After the addition of pyrocatechol the uv-vis spectra was scanned at 
regular time intervals for 25 min. and was also recorded after the duration of 24 hr. There 
was increase in the absorption in 26,315-25,000 cm'' region, with the course of reaction a 
sharp absorption emerged at 25,000 cm'' which is characteristic of oxidation of catechol 
to substituted o-quinones [206]. Oxygen directly participates in the catalytic cycle by 
reoxidising copper(l) species back to the active copper(Il) species. 
soo too 
Wovtltnglhlnm) 
Figure-3G. Oxidation of pyrocatechol by the dinuclear copper(II) complex. 
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1 5 10 
Time (min.) 
Figure-31. A comparison of time-dependent formation ofquinone by the complex 
[C22H52N10O2CU2]. (ClO^)^, at different concentrations of pyrocatechol 
representative curves (a) 3 xlff^ (b) 4 xlO'^ (c) 5 xlO'^ (d) 6 xW^ mol dm'\ 
The kinetics of the oxidation of catechol was determined by the method of initial rates 
versus the concentration of dinuclear complex by monitoring the growth of the 25,000 
cm"' band of the product o-benzoquinone. In order to determine the kinetic parameters, 
the Michaelis-Menten approach which originally developed for enzyme kinetics, was 
applied [207-209]. The parameters Vmax, KM were determined from Lineweaver-Burk 
plots (Figure-32) and a value of V a^x (2.8 x 10"^  MS"') and KM (1.4 x 10"^  mM) for the 
dinuclear copper complex was obtained, which indicate the second order kinetics with 
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respect to different concentrations of pyrocatechol. Tiie rate law which holds good for 
the kinetic reaction is, 
V = d[P]/dt = K+2[ES] = K+2[Eo][S]/[S] + KM 
where (V) is the rate of reaction at which the product is formed, 
or simplifying 
V = V„3X[S]/[S] + KM 
Where S is the concentration of substrate, Vmax is the maximum rate of reaction, 
which occurs when the enzyme is completely saturated with substrate and KM is the 
Michaelis constant. 
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Figu re-32. Kinetic parameters V„ax and KM have been determined by the plot of 
Vo (MS" ) versus concentrations of pyrocatechol. 
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CHAPTER V 
Synthesis of dithiocarbamate ciprofloxacin derivatives; 
Antibacterial activity and interaction of heterodinuclear copper 
tin complex with calf thymus DNA. 
CHAPTER V 
Experimental 
Ciprofloxacin hydrochloride (Rhydburg Pharmaceuticals Ltd.), carbon disulphidc 
(S.d. fme-ciiem Ltd.), NiCl2.6H20, CUCI2.2H2O (BDH), triphenyi tinchloride (Merck), 
were used as received without further purification. Calf thymus DNA was obtained from 
sigma. Microanalysis of the complexes were carried out on a Carlo Erba analyzer model 
1108. Molar conductance was measured at room temperature on a Digisun electronic 
conductivity bridge. Infrared spectra (400-4000 cm'') were recorded on a Shimadzu 8201 
PC spectrophotometer in Nujol mull. 'H and '•'C n.m.r. spectra were recorded on a Bruker 
DRX-300 spectrometer. The e.p.r. spectrum was run on a Varian El 12 spectrometer. 
High purity, HiO/MeOH (95:5) solvent was employed for the cyclic vollammetric 
studies. Kinetic experiments were performed at room temperature by using USB 2000 
Ocean Optics spectrometer. The fluorescence spectra was recorded on a Shimadzu 
spectrotluorometer, model RF-540 equipped with a data recorder, DR-3. 
SyiUhesis of (Cif,H,,2NiFO.iS2Snl 
Carbon disulphide (0.182 cm ,^ 0.002 mol) was added to a solution of ciprofloxacin 
(1.00 g. 0.002 mol) in DMF (40 cm )^ and triphenyi tinchloride (1.156 g, 0.002 mol) in 
1:1:1 molar ratio with constant stirring at a temperature maintained below 10 "C. The 
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reaction mixture was stirred for 1 h and a cream colored complex appears, which was 
washed thoroughly with hexane and dried in vacuo (Scheme 4). 
Synthesis offCjtiHjsNjFOsS^SnCuJ. CI 
To a solution of complex [C36H32N3F03S:Sn] (0.378 g, 0.001 mol) in MeOH (10 cm^) 
was added CuChlHiO (0.085 g, 0.001 mol) in 1:1 molar ratio and the mixture was 
refluxed for ca. 18 h. The resulting solution was concentrated to half the volume and 
allowed to cool overnight in refrigerator. A dark green colored complex was obtained, 
washed thoroughly with hexane and dried in vacuo. 
Synthesis offCuHssNiFOsSiSnNiJ. CI 
NiCb.dH.O (O.I 18 g. 0.001 mol) was added to a solution of complex [C36H32N3F03S2Sn] 
(0.378 g. 0.001 mol) in MeOH (10 cm )^ in 1:1 molar ratio and the mixture was refluxed 
for ca. 18 h. The resulting solution was allowed to cool overnight in refrigerator. A light 
green colored complex was obtained, washed thoroughly with hexane and dried in vacuo. 
Resu/ts and discussion 
Novel dinuclear complexes [C36H35N3F05S2SnCu].Cl and [C36H35N3F05S2SnNi].Cl have 
been synthesized by the reaction of ciprofloxacin with carbondisulphide, triphenyltin and 
transition metal CudI) and Ni(ll). The elemental analyses values (Table 9) were found to 
be in close agreement with the calculated values for the molecular formula assigned to 
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these complexes. They are stable in air at room temperature. Molar conductance values 
(10"^  M) in MeOH shows that they are 1:1 electrolytes. 
I.r. spectra 
The spectrum of ciprofloxacin exhibits medium intensity bands at 3378 cm"', 1708 cm' 
and 1625 cm'' which are attributed to v(NH), v(C=0) of carboxylic group and v(C=0) of 
keto group, respectively [210, 100]. In complex [C36H32N3F03S2Sn] (Table 10) the band 
attributed to v(NH) disappears suggesting the involvement of nitrogen of the piperazinc 
ring in dithiocarbamate formation by the deprotonation of NH and there is consequent 
coordination of sulphur atom to tin metal ion. The dithiocarbamate formation is further 
ascertained by emergence of two new sharp bands at 1009-1011 cm'' and 940-947 cm" 
assigned to v(CS2)asym and v(CS2)sym, respectively [211] and a v(C-N) band appears at 
1483 cm'. It is generally accepted that a value of Av (Vasym-Vsym) less than 200 cm ~ 
indicates the bidentate nature of ligand [212], however the Av value of [v(CS2)asym -
v(CS2)sym] is about 64 cm'" in the complex [C36H32N3F03S2Sn] which indicates that 
dithiocarbamate group is coordinated to tin in a bidentate fashion [213]. The relatively 
high value for v(C-N) is due to coordination of tin atom with -CS2 group and our results 
are consistent with earlier reports for analogous tin complexes [214,215]. The 
complexaiion of Sn(lV) with -CS2 group is supported by the appearance of bands in the 
region 466-468 cm' and 547-550 cm'' due to tin-sulphur v(Sn-S) and tin-carbon 
v(Sn-C) bond respectively [211]. in the i.r. spectrum of both the dinuclear complexes 
[C36H35N3F05S2SnCu].CI and [C36H35N3F05S2SnNi]. CI the stretching vibration of the 
pyridone (C=0) group is shifted to slightly higher wavenumbers (1638 cm"') and the 
band due to carboxylic group appears at 1383 cm''. These results indicate that the metal 
ion is coordinated with the pyridone oxygen atom and one of the carboxylic oxygen 
atoms of the quinolone molecule [216, 90]. The coordination of the transition metal ion is 
also ascertained by the characteristic band v(M-O) which appeared in the region 
430-432 cm''. 
E.p.r spectra 
The solid state X-band e.p.r spectrum of complex [CaeHasNsFOsSiSnCuJ.Cl was 
recorded at liquid nitrogen temperature LNT (77 K) (Figure-33). This complex was 
found to be anisotropic with 'g' values gn = 2.230, gi = 2.036 and gav = 2.100, 
respectively. The parameter gav was obtained according to the equation 
[(gav) = l/3(gii+2gi)] and is in good agreement with corresponding anisotropy in 
2 0 0 0 2 2 0 0 2tOO 2 6 0 0 2 6 0 0 3 0 0 0 3 2 0 0 3 4 0 0 3 6 0 0 3 6 0 0 « 0 0 0 
Magnetic f i« Id /Gauss 
Figure-33. The e.p.r. spectrum of the complex fC36H35N3FOsS2SnCuJ.Cl at LNT (77 K). 
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square-planar environment. The value of gii>gi which suggests that copper has square-
planar geometry around it. Further, it also supports the fact that the unpaired electron lies 
predominantly in the dx^-y^ orbital [217]. The g values are related to the axial symmetry 
parameter, G, by the Hathaway [218,219] expression G = (gii-2)/(gi-2). In the complex 
[C36H35N3F05S2SnCu].Cl, G value obtained was 6.38 which indicates that exchange 
interactions are absent. 
Electronic Spectra 
The electronic absorption spectra of the complexes reveals three strong bands at 43,478, 
35,714 and 30,303 cm'' respectively in MeOH. The first two bands are attributed to 
71-71* transitions and the band at 30,303 cm'' to n - 7t* transitions. 
The complex [C36H35N3F05S2SnCu].CI exhibits abroad band at 12,345 cm"'attributed 
to d-d transition ^B|g p. ^B2g which is in good agreement with square-planar 
geometry around the Cu(II) ion [220]. The electronic absorption spectrum of the complex 
[C36H35N3F05S2SnNi].Cl shows a band at 16,000 cm"' assigned to 'A|g • 'A2g 
transition indicating square-planar geometry around the Ni(II) ion. 
N.nur spectra 
In order to obtain a better understanding of the structure of the complexes 
[C36H32N3F03S2Sn] and [C36H35N3F05S2SnNi].Cl, 'H and '^ C n.m.r spectra were 
recorded in DMSO-d^ and D2O depicted in (Table 11 and 12). ' H n.m.r spectrum of 
complex [C36H32N3F03S2Sn] exhibit characteristic signals of phenyl and carboxylic acid 
protons at 7.3-7.8 ppm and 11.0 ppm, respectively [221,222]. The spectrum does not 
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show the signal attributed to -NH proton at 5.9 ppm, indicating the deprotonation ofNH 
proton of piperazine moiety and its subsequent participation in the dithiocarbamaic 
complex formation. 
'•'C n.m.r spectrum of the complex exhibits carboxylic acid carbon at 165 ppm and also 
registered two additional peaks in the range 135-136 and 176 ppm due to phenyl and 
CS2 carbons, respectively. Absence of-COOH protons in the 'H n.m.r spectrum of 
complex [C56H35N3FO.sS2SnNiJ.CI indicate the coordination of -COO" group oxygen 
with the metal ion. Other proton signals remain unaltered in the complex. 
Antibacterial activity 
The antibacterial activity of the complexes [C36H32N3F03S2Sn] and 
[C36lh5N3F05S2SnCu].CI against the bacteria E. Coli are presented in (Table 13). 
The clear zones around the discs indicate the inhibiting activity of the compound on the 
bacteria (Figure-34). In the Table, 4 mm represents no zones of inhibition. 
Mode of action of antimicrobials involve various targets in microorganism. 
e.g., interference with cell wall synthesis, damage to the cytoplasmic membrane as a 
result of which cell permeability may be altered or they may disorganize the lipoproteins 
leading to cell death [223]. 
It is evident from the antimicrobial screening data that the metal chelates are more potent 
than the parent ligands. The increased potency of metal complexes may be assigned to 
their increased lipophilic nature arising due to chelation [224]. Chelation considerably 
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reduces the polarity of the metal ion mainly because of partial sharing of its positive 
charge with donor groups and possiblcTt -delocalisation over the chelate ring. 
Figure- 34. The biological activity of ciprofloxacin tin-dithiocarbamate complexes, 1,2,3 
represents zone of inhibition of complex [C36H32N3F03S2SnJ at different 
concentrations 50, 12.5 and 3.1 ^  mV', while inhibition of complex 
[C36H3sN3F05S:^rtCu]. CI at different concentrations 50, 12.5 and 3.1 fg mt' 
is marked by 4, 5, 6. 
Electrochemistry 
The electrochemical behavior of complex [C36H35N3F05S2SnCu].Cl has been examined 
by cyclic voltammetry to study the metallointeraction. The cyclic voltammogram of the 
dinuclear complex in absence of calf thymus DNA recorded in MeOH/HaO (5:95) at a 
scan rate of 0.1 Vs ' in the potential range -1.2 to 1.6V vs. Ag/AgCl electrode is depicted 
in (Figure-35). It exhibits a well defined quasireversible redox wave Cu'VCu' attributed to 
one electron transfer process with Epc and Epa values at 0.020 V and -0.103 V, 
respectively. For this couple, the difference between the cathodic and anodic peak 
potentials, AEp is of the order 123 mV, a somewhat large peak to peak separation in 
comparison to Nernstian value (59 mV) observed for one electron transfer couple. 
The ratio of Ipc/lpa is less than unity (0.68). E1/2 value is equal to 0.041 V. The c.v. trace 
of the complex [C36H35N3F05S2SnCu].Cl in presence of CT-DNA shows a change in 
electrode potential Ep values, while the cathodic peak potential shifts to 0.072 V 
[in comparison to solution without CT-DNA (Epc = 0.020 V)] a shift of 0.052 V is 
observed (Figure-36). E1/2 value is equal to 0.015 V and the ratio of Ipc/lp;, = 0.315 V for 
the calf thymus DNA bound complex. Shift in E1/2 and Ep values with change in Ipc/lpa 
values suggest that the complex is strongly bound to DNA. 
1.6 1.2 0.8 0.4 0 -0.4 -0.8 -1.2 
P o t e n t i o l / V 
Figurc-35. Cyclic vollammogram of complex [C i^HisN^FO sS^SnCu] .CI in MeOH/H^O 
(5:95) cjl a scan rale ofO. 1 Vs''. 
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16 12 0 8 0 4 0 -0.4 
P o i e n t . o l / V 
-0.8 -1.2 
Figurc-36. Cyclic voltamnwgram of complex [Ci^Hi^NiFOsS^SnCuJ.Cl hoimd yvilh 
CT-DSA at a scan rale of 0.1 Vs''. 
DNA Binding Studies 
The binding of drug to DNA has been characterized through absorption titrations, 
following the hyperchromism and a blue shift of 4 nm associated with binding of the 
complex to the helix. Figure-37 displa>s a well behaved titration of a Hxed concentration 
of complex [C36H35N3F05S2SnCu].CI (8.3 x 10"^  M) in absence and in presence of 
increasing amounts-of calf thymus DNA (1.7-4.1 x 10' M). The specira clearly shous 
that the addition of DNA yields hyperchromism and the h\pcrchromiMii coniinues with 
respect to time. The spectral characteristics are attributed to a mode of binding that 
involves a strong stacking interaction between the complex and calf thymus DNA. On 
interaction of complex with DNA there are significant changes in the absorption spectra 
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which causes conformational changes in the DNA helix. The extent of spectral change is 
related to the strength of binding and the spectra for intercalators are more perturbed than 
those for groove binders. 
In order to assess the binding affinity of complex [C36H35N3F05S2SnCu].Cl and to gain 
some insight into their mode of binding to duplex DNA the intrinsic binding constant 
Kb was calculated by absorption spectral titration data using equation (3) [168a] 
(Figure-38). The binding constant value obtained for the complex was 1.1x10^ M''. This 
is indicative of the binding of the complex with DNA with an affinity close to that of 
classical intercalators. 
300 400 
Wovelength (nm ) 
500 
Figure-37. Absorption spectra of[C36H35N3F05S^nCu].Cl in the absence (- - -; and 
presence (—) of increasing amounts of DNA. Arrow shows the absorbance 
changes upon increasing DNA concentration. 
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[DNA]x lO-'M 
Figu rc-38. Plot of [DNAJ/ Ca. £/ versus [DMA] for the titration of DMA with the complex 
[CjoHjjNjFOsSjSnCuJ. CI. 
Viscosity Measurements 
To further clarify the nature of the interaction of complex [C36H35N3F05S2SnCu].CI to 
DNA, viscosity measurements were carried out on CT-DNA (8.3 x 10'^  M) by varying 
the concentration of the added complex (1.7-4.1 x 10"^  M) and the results are presented in 
(I igiire-39). I he experiment involves the measurement of the flow rate of DNA solution 
through a capillary viscometer, in the absence of crystailographic structural data, 
hydrodynamic measurements, which are sensitive to DNA length change (i.e. viscosity 
and sedimentation) are regarded as the least ambiguous and most critical tests of binding 
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in solution [225]. A classical intercalative mode causes a significant increase in viscosity 
of the DNA solution due to an increase in the separation of base pairs at the intercalation 
sites and hence an increase in overall DNA contour length. In contrast, a partial 
nonclassical intercalation of the ligand would reduce the DNA viscosity [226]. 
For the complex the relative viscosity of calf thymus DNA decreases by increasing the 
amount of complex. This may be due to the molecular structure of the complex, which 
could not completely inlcrcalaie. at most it could penetrate their substituted phenyl 
moieties into the DNA base pairs, leaving the other part of the ligand in the groove. This 
would cause a static bend or kink in the helix and decreases the viscosity of DNA. The 
experimental results suggest that the complex could bind to DNA by the partial 
nonclassical intercalation model. 
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Figu re-39. Effect of increasing amounts of complex fC36H35N3FOsS2SnCuJ. CI on the 
relative viscosities ofCT-DNA at 29.0 ± 0.1 "C 
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Fluorescence studies 
The interaction of the heterodinuclear [C36H35N3F05S2SnCu].Cl complex and DNA was 
further confirmed by fluorescence measurements. The fluorescence intensity at a fixed 
concentration of complex (1 x 10"^  M) was quenched with increasing concentrations of 
CT-DNA (3 X 10•^4 x \0'\ 5 x 10"^ 6x10'^ M) (Figure-40). The complex was excited at 
28, 571 cm"' and the emission intensity was monitored at 23, 255 cm"'. The fluorescence 
quenching constant was calculated using the Stern-Volmer equation IQ/I = 1+ Kb[DNA] 
[171]. The value of Kb which is a measure of the efficiency of quenching by DNA was 
obtained from the linear plot to be 4 x 10^  M"' (Figure-41). 
eo 
6 0 
A-O 
2 O 
0 
-
^ 
' 
^ ^ ° W o v e i e n g t h ( n m ) ^ ^ ° 
Figure-40. Fluorescence spectra of[C36H35N3FOsS2SnCuJ.a (1 x 10'^ M) with 
increasing concentration of CT-DNA in the range 3-6 x KT^ Mwith 
A^:cc= 28. 571 cm''. 
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Figu re-41. Stem- Volmer quenching phi of complex [C^oHssN^FOsS^SnCu]. CI with 
increasing concentration ofCT-DNA. 
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CHAPTER VI 
Synthesis^ characterization, electrochemistry and calf thymus 
DNA binding studies of dinuclear copper(II) complex of 
sparfloxacin. 
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CHAPTER VI 
Experimental 
Spartloxacin (Rhydburg Pharmaceuticals Ltd.), sodium hydroxide pellets (Ranbaxy), 
NiCI:.6I-l20. CuCl2.2H:0 (BDH) were used as received without further purification. Calf 
lh\mus DNA was obtained from sigma. Microanalysis of the complexes were obtained 
on a Carlo Erba Analyzer Model 1108. I.r. spectra (400-4000 cm'') were recorded on a 
Shinidd/u 8201 PC spectrophotometer in Nujol mull. The n.m.r. spectra were recorded on 
a Broker DRX-300 spectrometer. The e.p.r spectrum was run on a Varian El 12 
spectrometer. Molar conductance measurements were made on a Digisun Electronic 
conductivity bridge. The electrochemical behaviour of the dinuclear Cu(ll) complex and 
its interaction with CT-DNA were monitored by cyclic voltammetry in H^O/MeOH 
(95:5). The kinetic experiments were performed at room temperature using USB 2000 
Ocean Optics spectrometer. The fluorescence spectra was recorded on a Shimadzu 
spectrotluorometer. model RF-540 equipped with a data recorder, DR-3. 
Synthesis oflCi yH, 7F2N40iNa] 
To a solution of sparlloxaciii (2.00 g. 0.005 mol) in ethanol (50 cm )^ was added an 
ethanolic solution (10 cm )^ of NaOH (0.214 g, 0.005 mol) in 1:1 molar ratio and the 
mixture was relluxed for ca. 1 h and then filtered, cream colored product was obtained by 
the slow evaporation of the filterate at room temperature. It was collected, washed with 
hexane and dried in vacuo. 
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Synthesis of fCj4Hj4F4Ns06CuJ 
To a methanolic (30 cm^) solution of [C,7Hi7F2N403Na] (0.770 g, 0.002 mol) was added 
CUCI2.2H2O (0.170 g, 0.001 mol) in 2:1 molar ratio, immediately a dark green colored 
precipitate appears which was filtered, washed with hexane and dried in vacuo 
(Scheme 5). 
Synthesis of/Cj4H34F4Ns06Ni/ 
NiCl2.6H20 (0.237 g, 0.001 mol) was added to a methanolic (30 cm') solution of 
[Ci7Hi7F2N403Na] (0.770 g, 0.002 mol) in 1:2 molar ratio. Light green product was 
obtained immediately which was filtered, washed with hexane and dried in vacuo. 
Synthesis of/bis( ethylenecliamine)Cu(II)]chloride 
To a solution of copper chloride (l.71g, 0.01 mol) in MeOH (50 cm )^ was added 
ethylenediamine (1.34 cm'', 0.02 mol) in 1:2 molar ratio. A dark blue product was 
obtained, washed with ether and dried in vacuo. 
[bis( ethylenediamine)Ni (II)]chloride was also synthesized by the similar procedure. 
Synthesis oflCi8H4&F4Ni20sCu2l Ch 
To a solution of complex [C34H34F4Ng06Cu] (0.600 g, 0.0007 mol) in MeOH (20 cm"*) 
was added [bis(ethylenediamine)Cu(ll)]chioride (0.192 g, 0.0007 mol) in 1:1 molar ratio, 
the resulting mixture was refluxed for ca. 4 h to give a brown product, which was isolated 
by filtration, washed with hexane and dried in vacuo. 
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+ NaOH 1:1 
t^N^ )=0 
-HjO 
>-N: )=O 
/ 
2:1 -2NaCl[MCl2 
•NHj NHj 
^< )=«^  -^K >-^ 
\ = ^ ^ M V = / 
[M-Spar] 
MeOH [M-Spar] + [M(en)2]Cl2 .n Q * [M-Spar-(en*)2 M]. Clj 
Dinuclear complex 
Scheme 5: M = Ni(II), Cu(II) 
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Synthesis of[C3sH^sF4N,20sNi2/. CI2 
[bis(etliylenediamine)Ni(II)]chloride (0.190 g, 0.0007 mol) was added to 
[C34H34F4N806Ni] (0.600 g, 0.0007 mol) in MeOH (20 cm )^ in 1:1 molar ratio, the 
resulting mixture was refluxed for ca. 4 h to give a dark green product, which was 
isolated by filtration, washed with hexane and dried in vacuo. 
Results and Discussion 
The anaJNlical data shown in Table 14 support the formation of mononuclear complexes 
in 1:2 (metal-ligand) molar ratio and dinuclear complexes in 1:1 molar ratio. The isolated 
mononuclear and dinuclear complexes are stable at room temperature, non hygroscopic 
and insoluble in most organic solvents. However, the complexes are soluble in MeOH, 
DMF and DMSO. The molar conductance of monometallic complexes (10'' M) in MeOH 
indicate that they are non electrolytic in nature while the dinuclear complexes have molar 
conductance values of 167-169 ohm'' cm" moP' in MeOH indicating that these 
complexes are 1:2 electrolytes. 
I.r. spectra 
Important i.r. bands of the sparfloxacin drug, its mononuclear and dinuclear complexes 
are shown in Tabic 15. The mononuclear complexes exhibit characteristic bands of 
v(NH:). v(N-H). v(C-()). antisymmetric v(COO) and symmetric v(COO) at 3354-3356 
cm', 3418-3426 cm'. 1190-1195 cm'', 1518 cm''and 1444 cm"', respectively [210,227]. 
The coordination of metal ion involves the participation of v(C=0) of the aromatic 
pyridone conjugation and oxygen atom of the carboxylic acid group [90]. This is further 
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ascertained by the emergence of a new band in the region 516-520 cm"' attributed to 
v(M-O) [228]. 
The dinuclear complexes are formed by the interaction of metaliated ethylene diamine 
moiety via the formation of a -C=N bond, which is observed as a sharp band in 1635-
1638 cm"' region [229] while the other -NH2 groups of ethylcnediamine remain 
unaltered. The formation of dinuclear complexes is further authenticated by v(M-N) 
bands which appeared at 450-465 cm"' in the far i.r region [230|. Other bands of the 
fluoroquinolones (e.g. vC-F, vC-H and vNHi) remain unaltered in both mononuclear 
and dinuclear complexes indicating the non-participation of these groups in coordination. 
E.p.r spectra 
The solid state X-Band (~ 9.1 GHZ) e.p.r spectra of complex [C34H34F4Ng06Cu] and 
[C3gH4sF4Ni205Cu2].Cl2 wcrc recorded at liquid nitrogen temperature (LNT) (77K) 
and their gn, gi, gas and G values have been calculated. In monometallic Cu(ll) complex 
(Figure-42) each of the gn and gi components show hyperfine splitting into four lines, 
the hyperfine lines of gn are 2520, 2630, 2720, 2790 G and the hyperfine lines of gi are 
2860, 3010, 3200, 3260 G. From these data, the g-values are obtained as gn = 2.431 (Aav 
= 90 G) and g, = 2.102(Aav = 133 G). The parameter [(gav) = l/3(gn + 2g)] is found to be 
equal to 2.21. Thus it is clear that complex [C34H34F4N8O6CU] shows anisotropic e.p.r 
spectrum with gn>gi consistent with square-planar environment around Cu(ll) ion [231]. 
An isotropic broad signal centered at g = 2.10 is observed in the dinuclear copper(ll) 
complex (Figure-43), because of the antiferromagnetic interactions in the complex, 
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attributed to intramolecular interactions between the two copper centers, which may be 
transmitted through bonds or space [232]. 
2000 2400 2600 3200 3600 4000 
Magnetic field/Gouss 
Figure-42. X-band E.p. r spectra of C34H34F4N8O6CU at LNT (77K). 
2000 2t00 2800 3200 
Magnetic field/Gauss 
3600 4000 
Figure-43. E.p. r spectra ofdinuclear Cu(II) complex at LNT (77K). 
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Electronic spectra 
The mononuclear complex [C34H34F4N8O6CU] exhibits three bands, a broad band 
observed at 19,920 cm"' due to d-d transition of the metal ion, a moderate intense band at 
27.027 cm"' due to ligand to metal charge transfer transition and a strong band intraligand 
charge transfer transition at 35,087 cm"'. The absorption spectra displays the presence of 
Cu(ll) metal ion in the square-planar environment [233]. The dinuclear complex 
fC;sll4(,F4Ni:04Cu2].Cl2 shows two bands at 15,873 cm"' and 20,049 cm"' attributed to 
d-d transition "Big ^ "Aig and "Big • "Eg characteristic of square-planar 
environment [234] (Figure-44). 
Electronic absorption spectra of the mononuclear complex [C34H34F4N806Ni] shows a 
low energy intense band at 20,408 cm"' which can be attributed to 'Aig • 'B|g 
transition indicating the square-planar geometry of the complex. Similarly, electronic 
spectrum of the dinuclear complex [C38H48F4Ni205Ni2].Cl2 exhibits a band at 20,533 
cm" having the same origin as that in the spectrum of mononuclear nickel(II) complex, 
but another band is also observed at 16,666 cm' due to 'A|g ^ 'A2g transition, 
typical of square-planar nickel (II) complex [235-236]. 
100 
500 600 700 
Wavelength (nm) 
eoo 
Figurc-44. Represenlalive electronic speclritm of (a) fCs^HsjF^NsOoCiiJ and 
(b) [CisH.sF^NnOsCuJ.Ch. 
N.m.r spectra 
To elucidate the structure of the complexes ' H and '^C n.m.r spectra of 
[C34H34F4N806Ni] and [C3gH48F4Ni205Ni2].Cl2 have been carried out and are given in 
(Table 16 and 17). ' H n.m.r spectrum of [C34H34F4N806Ni] recorded in D2O exhibit 
signals at 5.8 and 4.6-4.8 ppm due to NH and NH2 protons. Absence of a signal at 12.0 
ppm due to COOH protons indicate the involvement of carboxylic group in the complex 
formation. The signals arrising from N-CH2-CH2-N and CH2(cycIopropane) protons 
appear at 3.4 and 2.6-2.7 ppm respectively [89]. The ' H n.m.r spectrum of dinuclear 
Ni ( l i ) complex shows all proton signals in the same range except two new signals at 3.0 
ppm and 2.30 ppm due to NH2 and -CH2-CH2- group of the [bis(en)Ni]'* moieiy [2371. 
These signals are slightly different from the sparfloxacin quinolone moiety, which alsi> 
have the same groups. 
C n.m.r spectra of the complex [C34H34F4N806Ni] exhibits signals at 160.0, 168.1, 8.0, 
157.3, 151.2 and 54.3 ppm due to - C = 0 , -0 -C=0- , -CH2-(cyclopropane), -C-F, -C-N and 
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N-CHi-CHi-N carbons respectively [89]. '^ C n.m.r spectra of the dinuclear nickel(ll) 
complex shows a signal due to the presence of-0-C=0- carbon along with a new signal 
at 147 ppm which was assigned to -C=N carbons [238], this indicates the formation of 
dinuclear Ni(ll) complex, which is further supported by the signal at 41.5 ppm due to 
-CH2-CH2- ethylene carbons [239]. Other proton and carbon signals remains unaltered. 
Electrochemical studies 
The electrochemical properties of the dinuclear complex [C38H48F4Ni205Cu2].Cl2 was 
studied by cyclic voltammetry at a scan rate of 0.1 Vs"' in the potential range from 1.6 to 
-1.2 V in HiO/MeOH (95:5). The cyclic voltammogram of free dinuclear Cu(ll) complex 
exhibits one electron quasi-reversible redox couple corresponding to the Cu'VCu' with 
anodic (oxidation) peak at -0.068 V and cathodic (reduction) peak at 0.062 V, 
respectively (Figure-45). For this couple, the difference between anodic and cathodic 
potential (AEp) is 0.13 V, the Ipa/lpc value is less than unity and E1/2 value is equal to 
0.003 V. At different scan rates there is no major change in Ep and E1/2 values indicating 
that Ep is independent of scan rates (Figure-46). 
On interaction of the dinuclear Cu(Il) complex with CT-DNA, there is a shift in AEp 
(Epa = -0.058 V and Epc = 0.042 V) as well as E1/2 values at the same scan rate. AEp and 
Ei/2 values was found to be equal to 0.10 V and 0.008 V (Figure-47). The ratio of Ipa/lpc is 
greater than unity for the CT-DNA bound complex which suggest that the absorption of 
Cu(l) product tends to be suppressed in the presence of calf thymus DNA. Further the 
shift in Ei/2 and AEp values indicate that the complex is strongly bound to CT-DNA. 
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Figure-46. Cyclic votliimmof^ram of Dimiclear Cu(ll) complex at different scan rates 
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Figure-47. Cyclic voltammogram of complex fC3sH^sf''-il^i203Cii2j.Ch hound with 
CT- DMA at a scan rale afO. 1 Vs'. 
DNA binding studies 
The binding of tlie diniiclcar complex [C3gH4sF4N|205Cu2].Ci2 with CT-DNA was 
ascertained by electronic absorption spectroscopy. Fixed amount of complex was titrated 
with increasing amount of DNA and electronic spectral traces are depicted in Figure-48. 
Upon addition of calf thymus DNA, absorption spectrum of complex indicates the 
significant "hypochromic effects" with a blue shift of 4 nm. These spectral characteristics 
suggest that complex interacts with DNA through a mode which involves a stacking 
interaction between aromatic chromophore and the base pairs of DNA due to the 
planarity of the ligand moiety. Moreover, the isobestic points at 310 nm and 360 nm 
suggest homogeneity of the complex-CTDNA binding. 
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Figure-48. The changes of absorption spectra of the complex [C38H48F4Ni20sCu2] .Ch 
in the absence (—) and presence (—) of increasing concentrations of 
CT-DNA. 
The intrinsic binding constant Kb of the complex was determined by monitoring the 
changes of absorbance in the intraligand charge transfer band with increasing 
concentration of DNA using equation (3) [168 a]. The Kb value of the complex was 
obtained to be 1.0 x 10^  M"' (Figure-49) which is much higher than the value of Kb of 
metallointercalators like ethidium bromide (1.25 x 10* M'') and dinuclear ruthenium 
complexes (0.76 x 10* M''). The large intrinsic binding constant values cannot be 
understood by simply comparing the sizes of conjugate planes of the intercalative 
fragments of these complexes. Norden suggests stabilization of noncovalent interaction 
with DNA in dinuclear Ru(ll) complexes by a threading multi-intercalation [168 b]. 
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Figure-49. Plot offDNAJ/ea-e/versus [DNA] for the titration ofDNA with the 
C o m p l e x [C38H48F4N,205CU2].Cl2. 
Viscosity studies 
To find the mode of binding of DNA with small molecules viscometric titration has also 
been employed. Intercalating agents are expected to destack the base pairs, thus causing 
an elongation of the double helix, and resulting in an increase in the viscosity of DNA 
[240], however non-intercalative binding is expected to produce no change or decrease in 
the viscosity of DNA [241]. The effect of complex [C38H48F4Ni205Cu2].Cl2 on the 
viscosity of DNA is shown in Figure-50. The relative specific viscosity of DNA increases 
with increasing concentration of the complex due to a lengthening of the DNA helix. This 
result supports the contention that complex binds to calf thymus DNA via. intercalation 
mode of binding and are further ascertained by Fluorescence titration experiments. 
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Fluorescence spectroscopic studies 
The results of the fluorescence titration of the complex [C38H48F4Ni205Cu2].Cl2 with 
DNA was illustrated in (Figure-51). Fi.xed amount of complex (Ix 10'^  M) were 
respectively titrated with increasing amounts of DNA, over a range of DNA 
concentration 3-6 x 10"* M. An excitation wavelength of 335 nm was used and the total 
emission intensity was monitored at 440 nm. Fluorescence intensity of the complex 
decreases steadily v\ith increasing addition of CT-DNA, this implies the interaction of 
complex with DNA. The fluorescence quenching constant was approximated by Stern-
Volmer equation [171] (IQ/I = I + Kb[DNA]). lo/l is plotted against the DNA 
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Figure-51 Fluorescence spectra of complex fC3sH^8F4Ni205Cu2j.Ch in absence 
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concentration and the Stern-Volmer constant was calculated by the ratio of the slope to 
the intercept. The plot is depicted in (Figure-52), and the quenching constant was 
estimated to be 2x 10'*M''. 
< 
-a 
CO 
o 
-o 
c 
o 
a. 
> 
u 
o 
CL." 
2 
3 
_o 
o (J 
c 
d 
U 
o 
o 
s 
:£ H: s 
•* -^  2 
00 
r<-) 
r t 
'—^  
^ 
• ^ 
r^  ( N 
• ^ 
o 
r o 
2^ 
00 
IT) 
c^ (~~-
i n 
c 
o 
CJ 
O 
5B 
SO 
(/) 
u X 
u 
D . 
P 
o 
U 
« Z r*-l 
o - T 
Z 
r i 
u. r-
• T " 
r-
u^  
3 
u «c 
o 30 
z T
r T 
"^ m I 
-T 
r'^ 
U^ 
m^  
z o 
o x; 
z 
_ n 
- t 
•^  
- T 
r n 
L^  
tN 
t^ 
O 
o o 
vd 
o 
m 
m 
m 
u-i 
\o 
0 0 
>o 
ON 
VO 
<N 
r~ 
IT) 
o 
i n 
C 
o 
U 
IT) 
r t 
• * 
O 
O N 
•^ 
T T 
00 
00 
O N 
oo 
c 
«J 
Ofl 
T3 
u 
u »A 
o r i 
Z 
•» 
U . 
ar 
3C 
f*^ 
o_ 
z 
•n 
o r i 
Z 
- T 
Lla 
3 0 
-r 
3C 
*^^  U^  
u 
o 
a. 
P 
S 
--> 
II 
• 
T3 
o 
o 
I 
:£ !^  - S 
,^  m *^  VI 
O 
CJ 
l O 
m 
vo 
00 
ro VO 
o 
u 
> 
o 
ON 
in 
ON 
in 
ON ON 
ON 
o 
O 
U 
• * 
• * 
^ 
•^  
• * 
•5}-
lO 
it 
O 
o 
u 
00 
>n 
ON 
»n 
00 
in 
o (N 
i n 
o 
<N 
m 
o 
> 
0 0 
^ M 
• * 
m 
00 
^ M 
• < * • 
f*^ 
o 
<N 
•<r 
m 
u 
& 
ii 
z 
M U 
X 
_u 
Q. 
E 
o 
CJ 
2 
O 
•<r 
z * N 
u. r^  
X 
r* 
u 
3 
^0 
o 0 0 
Z ^
 u. t f ^ 
I 
• ^ 
m 
u 
2 
so 
o 0 0 
2 ^
 u. 
^ r^ 
X 
Tt 
f^ 
u 
3 
u 
o 
2 
• ^ 
u-0 0 
•^  3: 0 0 
r^  
u 
2 
O 
2 TT 
tX 
oo 
• ^ 
3: 
oo (*1 
u 
X 
u 
X 
u 
o 
en 
X 
z 
p 
s 
c 
u 
X 
E 
o 
u 
c 
u 
E 
e 
o 
c 
R D. O 
b. C 
_o 
u 
I 
U 
z 
X 
u 
X 
z 
c 
o 
o 
I -c (J 
n 
E 
o 
r~; 
1 
vq 
r j 
O N 
( N 
1 
00 
<N 
00 
I 
0 0 
od 
I 
p 
00 
OS 
I 
IT) 
0 0 
0 0 
u 
y 
u 
c. 
E 
o O 
Z 
o 
00 2 
UU 
• ^ 
f ^ 
(^  
u 
z 
o 
2 
U. 
0 0 
T t 
0 0 
f*% 
CJ 
E 
c 
3 
V3 
E 
o 
u 
u 
en 
u 
E 
s 
U 
u 
I 
u 
2 
II U 
u 
I 
r i 
X 
u 
z 
I 
u 
I 
u. 
I 
o 
u 
c 
re 
c 
O 
L . 
D. O 
U 
o 
II 
u 
I 
o 
I 
o 
II 
u 
c 
o 
E 
o 
Q. 
E 
o U 
o 
oc 
O 
in 
(N 
2 
o 
00 
X. 
u 
oo 
00 
r j 
0 0 
2 
o 
REFERENCES 
13 
REFERENCES 
1. P. Nordlund, B. M. Sjoberg and H. Ekiund, Nature (London), 345, 593 (1990). 
2. A. C. Rosenzweig, C. A. Frederick, S. J. Lippard and P. Nordlund, Nature 
(London), 366, 537(1993). 
3. R. E. Stenkamp. Chem. Rev., 94, 715 (1994). 
4. E. Jabri, M. B. Carr, R. P. Hausinger and P.A. Karplus, Science (Washington, D. 
C), 268, 998(1995). 
5. N. Strater, T. Klabunde, T. Paul, H. Witzel and B. Krebs, Science (Washington, 
D. C.),268, 1489(1995). 
6. D. T. Logan, X. D. Su, A. Oberg, K. Regnstrom, J. Hajdu, H. Ekiund and P. 
Nordlund, Structure, 4, 1053 (1996). 
7. Z. F. Kanyo, L. R. Scolnick, D. E. Ash and D. W. Christianson, Nature (London), 
383,554(1996). 
8. D. A. Whittington and S. J. Lippard, J. Am. Chem. Soc, 123, 827 (2001). 
9. J. D. Cox, E. Cama, D. M, Colleiuori, S. Pethe, J. L. Boucher, D. Mansuy, D. E. 
Ash and D. W. Christianson, Biochemistry, 40, 2689 (2001). 
10. C. Gerdcmann. C. Eicken and B. Krebs, Ace. Chem. Res., 35, 183 (2002). 
11. A. Hazell. K. B. Jensen, C. J. Mckenzie and H. Toftlund, J. Chem. Soc, Dalton. 
Trans., 3249(1993). 
12. D. D. Lecloux and S. J. Lippard, Inorg. Chem., 36, 4035 (1997). 
14 
13. C. He and S. J. Lippard, J. Am. Chem. Soc, 120, 105 (1998). 
14. J. L Chou, D. N. Horng, J. P. Chyn, K. M. Lee, F. L. Urbach, G. H. Lee and H. L. 
Tsai, Inorg. Chem. Commun., 2, 392 (1999). 
15. F. Meyer, E. Kaifer, P. Kircher, K. Heinze and H. Pritzkow, Chem.-Eur. J., 5, 
1617(1999). 
16. J. G. Haasnoot. Coord. Chem. Rev., 131 (2000). 
17. C. Incarvito. A. I,. Rheingold, C. J. Qin, A. L. Gavrilova and B. Bosnich, Inorg. 
Chem., 40. 1386(2001). 
18. A. L. Gavrilova. C. J. Qin, R. D. Sommer, A. L. Rheingold and B. Bosnich, J. 
Am. Chem. Soc. 124,1714 (2002). 
19. S. S. Tandon. L. K. Thompson, M. E. Manuel and J. N. Bridson, Inorg. Chem., 
33,5555(1994). 
20. C. J. Sumby and P. J. Steel, Inorg. Chem. Commun., 6, 127 (2003). 
21. L. Dubois, D. F. Xiang, X. S. Tan, J. Pecaut, P. Jones, S. Baudron, L. L. Pape, J. 
M. Latour, C. BalTert, S. C. Noblat, M. N. Collomb and A. Deronzier, Inorg. 
Chem., 42, 750 (2003). 
22. T. Tanase and S. J. Lippard. Inorg. Chem., 34, 4682 (1995). 
23. T. Tanase, J. W. Vun and S. J. Lippard. Inorg. Chem., 35, 3585 (1996). 
24. S. Herold and S. J. Lippard. J. Am. Chem. Soc, 119, 145 (1997). 
25. S. Herold and S. J. Lippard, Inorg. Chem., 36, 50 (1997). 
26. R. H. Beer, W. B. Tolman, S. G. Bott and S. J. Lippard, Inorg. Chem., 28, 4557 
(1989). 
15 
27. R. H. Beer, W. B. Tolman, S. G. Bott and S. J. Lippard, Inorg. Chem., 30, 2082 
(1991). 
28. D. D. Lecloux, A. M. Barrios, T. J. Mizoguchi and S. J. Lippard, J. Am. Chem. 
Soc, 120,9001 (1998). 
29. T. J. Mizoguchi, R. M. Davydov and S. J. Lippard, Inorg. Chem., 38, 4098 
(1999). 
30. T. J. Mizoguchi, J. Kuzelka, B. Spingler, J. DuBois, R. M. Davydov, B. Hedman. 
K. O. Hodgson and S. J. Lippard, Inorg. Chem., 40, 4662 (2001). 
31. X. H. Bu, S. L. Lu, R. H. Zhang, D. Z. Liao, S. Aoki, T. Clifford and E. Kimura, 
Inorg. Chim. Acta, 298, 50 (2000). 
32. M. Suzuki, Pure Appl. Chem., 70, 955 (1998). 
33. Y. Dong, S. Yan,. V. G. Young Jr., and. L. Que Jr., Angew. Chem. Int. Ed. Engl., 
35,618(1996). 
34. F. Zippel, F. Ahlers, R. Werner, W. Haase, H. F. Nolting and B. Krebs, Inorg. 
Chem., 35, 3409(1996). 
35. P. Gamez, J. V. Harras, O. Roubeau, W. L. Driessen and J. Reedijk, Inorg. Chim. 
Acta., 324, 27 (2001). 
36. T. Gajda, A. Jansco, S. Mikkola, H. Lonnberg and H. Sirges, J. Chem. Soc. 
Dalton. Trans., 1757(2002). 
37. W. Kaim and J. Rail, Angew. Chem., Int. Ed. Engl. 35, 43 (1996). 
116 
38. A. Rompei, H. Fischer, D. Meiwes, K. B. Karentzopoulos, R. Dillinger, F. 
Tuczek, H. Witzel and B. Krebs, J. Biol. Inorg. Chem., 4, 56 (1999). 
39. C. Gerdemann, C. Eicken and B. Krebs, Ace. Chem. Res., 35, 183 (2002). 
40. J. P. Piquemai, J, Maddaluno., B. Silvi and C. G. Prettre, New. J. Chem., 27, 909 
(2003). 
41. H. Decker, R. Dillinger and F. Tuczek, Angew. Chem., Int. Ed. 39, 1591 (2000). 
42. H. Decker and F. Tuczek, Trends Biochem. Sci,. 25, 392 (2000). 
43. J. A. Goodwin, D. M. Stanbury, L. J. Wilson, C. W. Eigenbrot and W. R. Scheldt, 
J. Am. Chem. Soc, 109, 2979 (1987). 
44. J. Goodwin, G. Bodager, L. Wilson, D. Stanbury and W. Scheldt, Inorg. Chem., 
28, 35(1989). 
45. Z. Tyeklar, R. R. Jacobson, N. Wei, N. N. Murthy, J. Zubieta and K. D. Karlin, J. 
Am. Chem. Soc, 115, 2677 (1993). 
46. N. Wei, D. H. Lee, N. N. Murthy, Z. Tyeklar, K. D. Karlin, S. Kaderli, B. Jung 
and A.D. Zuberbuhler, Inorg. Chem., 33, 4625 (1994). 
47. D. E. Root, M. Mahrooftahir, K. D. Karlin and E. I. Solomon, Inorg. Chem., 37, 
4838(1998). 
48. 11. Borzel, P. Comba, K. S. Hagen, C. Katsichtis and H. Pritzkow, Chem. Eur. J., 
6,914(2000). 
49. M. Weitzer, M. Schatz, F. Hampel, F. W. Heinemann and S. J. Schindler, J. 
Chem. Soc, Dalton Trans., 5, 686 (2002). 
117 
50. H. Saimiya, Y. Siinatsuki, M. Kojima, S. Kashino, T. Kambe, M. Hirotsu, H. 
Akashi, K. Nakajima and T. Tokii, J. Chem. Soc, Dalton Trans., 3737 (2002). 
51. A. R. Fortea, P. Alemany, S. Alvarez and E. Ruiz, Inorg. Chem., 41, 3769 (2002). 
52. M. G. Kanatzidis. N. C. Baenziger and D. Coucouvanis, Inorg. Chem., 24, 2680 
(1985). 
53. M. R. Caira, K. R. Koch and C. Sacht, Acta Crystallogr., Sect. C. Cryst. Struct. 
Comnuin.. 47. 29(1991). 
54. J. Hanss and II. .1. Kruger, Angew. Chem., Int. Ed. Engl., 35, 2827 (1996). 
55. R. Ruiz. C. S. Barland, A. Aukauloo, E. A. Mallart, Y. Journaux, J. Cano and M. 
C. J. Munoz. .1. Chem. Soc. Dalton Trans., 745 (1997). 
56. S. Will, J. Lex. E. Vogel, H. Schmickler, J. P. Gisselbrecht, C. Haybtmann, M. 
Bernard and M. Gross. Angew. Chem., Int. Ed. Engl., 36, 357 (1997). 
57. M. P. Youngblood and D. W. Margerum, Inorg. Chem., 19, 3068 (1980). 
58. W. Klemm and E. Z. Huss, Anorg. Chem., 258, 221 (1949). 
59. C. Krebs, T. Glascr, E. Bill, T. Weyhermuller, W. M. Klaucke and K. Wieghardt, 
Angew. Chem.. Int. Ed., 38, 359 (1999). 
60. E. I. Solomon, Comm. Inorg. Chem.. 3, 227 (1984). 
61. J. L. Dubois. P. Mukherjee. A. M. Collier. J. M. Mayer. E. 1. Solomon, B. 
Hedman, T. D. P. Stack and K. O. Hodgson, J. Am. Chem. Soc, 119, 8578 
(1997). 
62. R. A. Scott, In Physical Methods in Bioinorganic Chemistry., L. Que Jr., Ed., 
University Science Books: Sausaiito, CA, (2000). 
63. B. Gyurcsik, T. Gajda, L. Nagy and K. Burger, J. Chem. Soc, Dalton Trans., 
2787(1992). 
64. K. Hegetschweiler, M. Ghisletta and V. Gramlich, Inorg. Chem., 32, 2699 (1993). 
65. S. Wang, S. J. Trepanier, J. C. Zheng, Z. Pang and M. J. Wagner, Inorg. Chem.. 
31,2118(1992). 
66. A.L. Feig, M. Becker, S. Schindler, R.V. Eldik and S. J. Lippard, Inorg. Chem.. 
35,2590(1996). 
67. A. Neves, L. M. Rossi, I. Vencato, V. Drago, W. Haase and R. Werner, Inorg. 
Chim. Acta., 281, 111(1998). 
68. K. Yamaguchi, F. Akagi, S. Fujinama, M. Suzuki, M. Shionoya and S. Suzuki, 
Chem. Commun., 375 (2001). 
69. Y. Dong, S. Menage, B. A. Brennan, T. E. Elgren, H. G. Jang, L. L. Pearce and L. 
QueJr.,J. Am. Chem. Soc, 115, 1851 (1993). 
70. M. K. Chan and W. H. Armstrong, J. Am. Chem. Soc, 112,4985 (1990). 
71. M. Suzuki, H. Senda, M. suenga, T. Sugisawa and A. Uehara, Chem. Lett., 923 
(1990). 
72. M. Yashiro, A. Ishikubo and M. Komiyama, J. Chem. Soc, Chem. Commun., 
1793(1995). 
73. S. T. Frey, N. N. Murthy, S. T. Weintraub, L. K. Thompson and K. D. Karlin, 
19 
Inorg. Chem.,36,956(1997). 
74. M. Suzuki, T. Sugisawaand A. Uehara, Bull. Chem. Soc. Jpn., 63, 1115 (1990). 
75. T. Kayatani, Y. Hayashi, M. Suzuki and A. Uehara, Bull. Chem. Soc. Jpn., 67, 
2980(1994). 
76. J. Urbanska and H. Kozlowski, J. Coord. Chem., 21, 175 (1990). 
77. H. Kozlowski, B. Radomska, T. Kiss, A. Temeriusz and J. Stepinski, J. Coord. 
Chem., 30, 215(1993). 
78. M. J. Bojczuk, H. Kozlowski, T. Trnka and M. Cerny, Carbohydr. Res., 253, 19 
(1994) and references therein. 
79. M. J. Bojczuk, H. Kozlowski, S. Lamotte, P. Decock, A. Temeriusz, 1. 
Zajaczkowski and J. Stepinski, J. Chem. Soc, Dalton Trans., 2657 (1995). 
80. M. J. Bojczuk, S. Lamotte, H. Kozlowski, A. Temeriusz, I. Zajaczkowski, J. 
Stepinski and P. Decock, J. Chem. Soc. Dalton Trans., 3849 (1995). 
81. B. Macias, M. Martinez, A. Sanchez and A. D. Gil, Int J Pharm., 106, 229 (1994). 
82. B. Macias, M. V. Villa, 1. Rubio, A. Castineiras and J. Borras, J. Inorg^Biochem., 
84, 163(2001). 
83. B. Macias, M. V. Villa, M. Sastre, A. Castineiras and J. Borras, Journal of 
Pharmaceutical Sciences, 91, 2416 (2002). 
84. S. A. Brown, J. Vet. Pharmacol. Then, 19, 1 (1996). 
85. M. Ruiz, R. Ortiz, L. Perello, J. Latorre and J. S. Carrio, J. inorg. Biochem., 65, 
87(1997). 
120 
86. 1. Turel, L. Golic and O.L. R. Ramirez, Acta Chim. Slov. 46(2), 203 (1999). 
87. A. Koppenhoefer, U. Hartmann, H. Vahrenkamp, Chem. Ber., 128, 779 (1995). 
88. M. Zupancic, I. Arcon, P. Bukovec and A. Kodre, Croatica Chemica Acta, 
CCACAA 75(1), 1 (2002). 
89. A. A. Tak. F. Arjmand and S. Tabassum, Transition Metal Chemistry, 27, 741 
(2002). 
90. G. Wu. Ci. Wang. X. Fu and L. Zhu. Molecules, 8, 287 (2003). 
91. O. R. Idowii and J. O. Peggins. Journal of pharmaceutical and Biomedical 
Analysis, 35. 143(2004). 
92. I. Turcl. I. Leban and N. Bukovec, J. Inorg. Biochem., 66, 241 (1997). 
93. 1. Turel. L. Golic. P. Bukovec and M. Gubina, J. Inorg. Biochem., 71, 53 (1998). 
94. P. Yang. .1. B. Li. Y. N. Tian and K. B. Yu. Chin. Chem. Let., 10, 879 (1999). 
95. G. P. Wang. G. Q. Cai and L. G. Zhu. Chin. J. Inorg. Chem., 6, 987 (2000). 
96. I. Turel. 1. Leban and N. Bukovec, J. Inorg. Biochem., 56, 273 (1994). 
97. 1. Turel. N. Bukovec and E. Farkas. Polyhedron, 15, 269 (1996). 
98. I. Turel, 1. Leban, M. Zupancic, P. Bukovec and K. Gruber, Acta Crystallogr., 
Sect. C. 52. 2443(1996). 
99. M. Zupancic and P. Bukovec, Acta Pharm.. 46. 221 (1996). 
100. M. Zupancic, I. Turel, P. Bukovec. A. J. P. White and D. J. Williams, Croat. 
Chem. Acta. 74(1), 61 (2001). 
101. J. H. Borrel and M. T. Montero, J. Chem. Educ, 47, 1311 (1997). 
121 
102. L. Wang, Analytical Sciences, 20, 1237 (2004). 
103. T. N. Xu, Biochemical Pharmacy, Preparation Branch , 13(5), 285 (1992). 
104. S. Jain, N. K. Jain and K. S. Pitre, Journal of Pharmaceutical and Biomedical 
Analysis, 29, 795 (2002). 
105. K. E. Brighty and T. D. Gootz, Journal of Antimicrobial Chemotherapy. 39. 
Suppl. B, 1 (1997). 
106. G. S. Son, J. Yeo, M. Kim, S. K. Kim, A. Hoimen, B. Akerman and B. Norden. J. 
Am. Chem. Soc. 120, 6451 (1998). 
107. S. Sortino and G. Condorelli, New. J. Chem., 26, 250 (2002). ..^-' 
108. J. 1. Kato, Y. Nishimura, R. Imamura, H. Niki, S. Hiraga and H. Suzuki, 63, 393 
(1990). 
109. L. L. Shen and A. G. Pernet, Proc. Natl. Acad. Sci., USA, 82, 307 (1985). 
110. L. L. Shen, J. Baranowski and A. G. Pernet, Biochemistry, 28, 3879 (1989). 
111. R. D. Snyder and C. S. Cooper, Photochem. Photobiol., 69, 288 (1999). 
112. R. Menzel and M. Gellert, Advances in pharmacology, 29A, 39 (1994). 
113. L. L. Shen, W. E. Kohlbrenner, D. Weigl and J. Baranowsji, J. Biol. Chem., 264, 
2973(1989). 
114. S. Redl and S. Dax, Current Medicinal Chemistry, 1, 262 (1994). 
115. L. L. Shen, L. A. Mitscher, P. N. Sharma, T. J. O. Donnel, D. W. T. Chu, C. S. 
Cooper, T. Rosen and A. G. Pernet, Biochemistry, 28, 3886 (1989). 
116. J. A. Ibers and R. H. Holm, Science (D. C. Washington), 209, 223 (1980). 
122 
117. S. J. Lippard, Angew. Chem., Int. Ed. Engl., 27, 344 (1988). 
118. L. Que Jr., and R. C. Scarrow, In Metal Clusters in Proteins, L. Que Jr., (Ed) ACS 
Symposium Series 372., American Chemical Society. Washington, DC, 159 
(1988). 
119. M. Regiier, C. Jorand and B. Waegell, J. Chem. Soc, Chem. Commun., 1752 
(1990). 
120. M. J. Henson and E. I. Solomon, Chemtracts -Inorg. Chem., 13, 97 (2000). 
121. W. Plass and J. G. Verkade, J. Am. Chem. Soc, 114, 2275 (1992). 
122. A. Diebold, A. Elbouadili and K. S. Hagen, Inorg. Chem., 39, 3915 (2000). 
123. D. A. Evans, T. Rovis, M. C. Kozlowski, C. W. Downey and J. S. Tedrow, J. Am. 
Chem. Soc, 122,9134(2000). 
124. E. N. Jacobsen. Ace Chem. Res., 33, 421 (2000) and references therein. 
125. M. Suzuki, H. Furutachi and H. Okawa, Coord. Chem. Rev., 200-202, 105 (2000). 
126. C. X. Zhang, H. C. Liang, K. J. Humphreys and K. D. Karlin, In Advances in 
Catalytic Activation of Dioxygen by Metal Complexes (L. 1. Simandi, Ed); 
Catalysis by Metal Complexes, (B. R. James, P. W. N. M. Van Leeuwen, Eds.); 
Kluvver: Dordrecht, Boston, London, 26, 79 (2003). 
127. R. C. Mehrota. R. Bohra and D. P. Gaur, Metal P-diketonates and Allied 
Derivatives; Academic Press, San Francisco, CA, (1978). 
128. B. K. Keppler, New. J. Chem., 14, 403 (1990). 
129. T. N. Sorrel 1, Tetrahedron, 45, 3 (1989). 
123 
130. P. A. Vigato, S. Tamburini and D. Fenton, Coord. Chem. Rev., 106, 25 (1990). 
131. N. Kitajima, Adv. Inorg. Chem., 39, 1 (1992). 
132. J. G. Verkade, Ace. Chem. Res., 26, 483 (1993). 
133. V. G. Makhankova, 0. Y. Vassilyeva, V. N. Kokozay,. B. W. Skelton, J. Reedijk, 
G. A. V. Albada. L. Sorace and D. Gatteschi, New. J. Chem., 25, 685 (2001). 
134. A. A. Naiini, J. Pinkas, W. Plass, V. Young and J. G. Verkade, Inorg. Chem., 33, 
2137(1994). 
135. A. A. Naiini. V. Young and J. G. Verkade, Polyhedron, 14, 393 (1995). 
136. J. Pinkas. J. C. HulTman, J. C. Bollinger, W. E. Streib, D. V. Baxter, M. H. 
Chisholm and K. G. Cauton, Inorg. Chem., 36, 2930 (1997). 
137. R. W. Saalfrank. I. Bernt, E. Uller and F. Hampel, Angew. Chem., Int. Ed. Engl, 
36.2482(1997). 
138. H. E. Parge. R. A. Hallewell and J. A. Tainer, Proc. Natl. Acad. Sci., U.S.A., 89, 
6109(1992). 
139. 1. Turel, A. Sonc. M. Zupancic, K. Sepcic and T. Turk, Metal Based Drugs, 7, 101 
(2000). 
140. P. Bhalla, S. Vidhani, B. S. N. Reddy. S. Chowdhry and M. D. Mathur, Indian J. 
Med. Res., 115, 113(2002). 
141. V. K. Agrawal, S. Bano, K. C. Mathur and P. V. Khadikar, Indian J. Chem., 38A, 
1203(1999). 
124 
142. M. V. Jesudason, V. Balaji and C. J. Thomson, Indian J. Med. Res., 116, 96 
(2002). 
143. D. Rehder, J. C. Pessoa, C. F. G. C. Geraides, T. Kabanos, T. Kiss, B. Meier, G. 
Micera, L. Petterson, M. Rangel, A. Salifoglou, I.Turel and D. Wang, J. Biol. 
Inorg. Chem., 7, 384 (2002). 
144. M. P. L. Gresa, R. Ortiz, L. Parelio, J. Latorre, M. L. Gonzalez, S. G. Granda, M. 
P. Priede and E. Canton, J. Inorg. Biochem., 92, 65 (2002). 
145. D. K. Demertzi, P. Kyrkon and 1. Zakharoba, Polyhedron, 10, 1507 (1991). 
146. G. Gervasio, S. Vastag, G. Szalontai and L. Marko, J. Organomet. Chem., 533, 
187 (1997) and references therein. 
147. C. C. Tai, J. Pitts, J. C. Linehan, A. D. Main, P. Munshi and P. G^Jessop, Inorg. 
Chem., 41, 1606 (2002) and references therein. 
148. D. Seyferth, G. B. Womack, M. Cowie and B. W. Hames, Organometallics, 3, 
1891 (1984). 
149. M. Nath and R. Yadav, Bull. Chem. Soc. Japan, 70, 1331 (1997). 
150. M. S. Singh and K. Tawade, Indian Journal of Chemistry, 41B, 419 (2002). 
151. K. G. Schrantz, A. Jancso, C. Pettinari and T. Gajda, Dalton Trans., 2912 (2003). 
152. C. Ma, Y. Han, R. Zhang and D. Wang, Dalton Trans., 1832, (2004). 
153. Z. Guo and P. J. Sadler, Med. Inorg. Chem., 49, 183 (2000). 
154. A. Rodger, K. K. Patel, K. J. Sanders, M. Datt, C. Sacht and M. J. Hannon, J. 
Chem. Soc, Dalton Trans., 3656 (2002). 
125 
155. X. Wang, X. Zhang, J. Lin, J. Chen, Q. Xu and Z. Guo, Dalton Trans., 2379 
(2003). 
156. M. J. Clarke, F. Zhu and D. R. Frasca, Chem. Rev., 99, 2511 (1999). 
157. H. Xu, K. C. Zheng, H. Deng, L. J. Lin, Q. L. Zhang and L. N. Ji, New. J. Chem., 
27, 1255(2003). 
158. G. Zuber, J. C. Quada Jr.vand S. M. Hecht, J. Am. Chem. Soc, 120, 9368 (1998). 
159. K. Nakamoto, "Infrared and Raman Spectra of Inorganic and Coordination 
Compounds", Wiley, New York, (1986). 
160. B. E. Douglas, D. H. McDaniel, J. J. Alexander, "Concept and Models of 
Inorganic Chemistry" J. Wiley and Sons, Inc., New York, (1993). 
161. R. S. Drago, "Physical Methods in Inorganic Chemistry," Reinhold Publishing 
Corporation, New York, (1968). 
162. A. J. Bard andFaulkner.'L. R. "Electrochemical Methods", Wiely, New York, p. 
219(1980). 
163. W. J. Geary, Coord. Chem. Rev., 7, 81 (1971). 
164. B. J. Hathaway, D. G. Holah and J. D. Postlethwaite, J. Chem. Soc, 3215 (1961). 
165. K. J. Laidler, "Chemical Kinetics" Tata McGraw Hill Inc., New York, (1973). 
166. A. A. Frost and R. G. Pearson, "Kinetics and Mechanism", Ed. John Wiley and 
Sons, New York, 11 (1961). 
167. A. Neves, L. M. Rossi, A. J. Bortoluzzi, B. Szpoganicz, C. Wiezbicki, E. 
Schwingel, V 
W. Haase and S. Ostrovsky, Inorg. Chem., 41,1788 (2002). 
168. (a) A. Wolfe, G. H. Shimer and T. Meehan, Biochemistry, 26,6392 (1987). 
(b) B. Onfelt, P. Lincoln and B. Norden, J. Am. Chem. Soc, 121,10846 (1999). 
169. J. M. Marmur, J. Mol. Biol., 3,208 (1961); M. E. Reichmann, S. A Rice, C. A. 
Thomas and P. Doty, J. Am. Chem. Soc, 76, 3047 (1954). 
170. M. Eriksson, M. Leijon, C. Hiort, B. Norden and A. Graslund, Biochemistry, 33, 
5031(1994). 
171. J. R. Lakowicz and G. Webber, Biochemistry, 12, 4161 (1973). 
172. R. S. Verma and W. L. Nobles, J. Pharm. Sci., 64, 881 (1975). 
173. S. Srinivasan, P. Athappan and G. Rajagopal, Transition Met.-Chem., 26, 588 
(2001). 
174. K. Nakamoto, The infrared spectra of inorganic and coordination compounds, 
3'** edn, New York, Wiley interscience, (1978). 
175. L. Tian, B. Zhao, Z. Zhou, Q. Yu and W. Yu, Synth. React. Inorg. Met. Org. 
Chem., 32(5), 939 (2002). 
176. B. N. Figgis and J. Lewis, Prog. Inorg. Chem., 37,37 (1964). 
177. Y. Dong, G. A. Lawraijce, L. F. Lindoy and P. Turner, J. Chem. Soc, Dalton 
Trans., 1567(2003). 
178. Y. Dong, L. F. Lindoy, P. Turner and G. Wei, J. Chem. Soc, Dalton Trans., 1264 
(2004). 
179. R. Buxtrof and T. A. Kaden, Helv. Chim. Acta., 66,86 (1983). 
180. L. Fabbrizzi, L. Montagna, A. Poggi, T. A. Kaden and L. C. Siegfried, J. Chem. 
Soc, Dalton Trans., 2631 (1987). 
181. J. A. Halfen, D. C. Fox, M. P. Mehn and L. Que. Jr., Inorg. Chem., 40, 5060 
(2001). 
127 
182. F. A. Bovey, " N.M.R. Data Tables For Organic Compounds", Wiley, New York, 
1,44(1967). 
183. R. H. Thomson. Naturally Occurring Quinones, 2"'' ed; Academic Press: London 
and New York, 48(1971). 
184. S. R. Cooper, Y. B. Koh and K. N. Raymond, J. Am. Chem. Soc, 104, 5092 
(1982). 
185. H. Grove, T. L. Kelly, L. K. Thompson, L. Zhao, Z. Xu, T. S. M. Abedin, D.O. 
Miller, A. E. Goeta, C. Wilson and J. A. K. Howard, Inorg. Chem.. 43, 4278 
(2004). 
186. T. Clifford, A. M. Danby, P. Lightfoot, D. T. Richens and R. W. Hay, J. Chem. 
Soc, Dalton Trans., 240 (2001). 
187. L. Tei, A. J. Blake, A. Bencini, B. Valtancoli, C. Wilson and M. Schroder, J. 
Chem. Soc, Dalton Trans., 4122 (2000). 
188. S. Gou, M. Qian, Z. Yu, C. Duan, X. Sun and W. Huang, J. Chem. Soc, Dalton 
Trans., 3232(2001). 
189. J. Sanmartin, M. R. Bermejo, A. M. G. Deibe, O. R. Nascimento, L. Lezama 
and T. Rojo, J. Chem. Soc, Dalton Trans., 1030 (2002). 
190. K. H. Reddy, M. S. Babu, P. S. Babu and S. Dayananda, Indian Journal of 
Chemistry, 43A, 1233(2004). 
191. B. Z. Lin and S. X. Liu, J. Chem. Soc, Dalton Trans., 865 (2002). 
192. C. Hemmert, H. Gornitzka and B. Meunier, New J. Chem., 24, 949 (2000). 
193. L. Ballester, A. M. Gil, A. Gutierrez, M. F. Perpinan, M. T. Azcondo, A. E. 
128 
Sanchez, E. Coronado and C. J. G. Garcia, Inorg. Chem., 39, 2837 (2000). 
194. N. Raman, A. Kulandaisamy and K. Jeyasubramanian, Indian J. Chem., 41 A, 942 
(2002). 
195. M. C. Jain, A. K. Srivastava and P. C. Jain, inorg. Chim. Acta, 23, 199 (1977). 
196. K. K. Nanda, A. W. Addison, N. Paterson, E. Sinn, L. K. Thompson and 
I). Sakaguchi, Inorg. Chem., 37, 1028 (1998). 
197. 1- Bcnisvy, A. J. Blake, D. Collison, E. S. Davies, C. D. Garner, E. J. L. Mclnnes, 
J. McMaster, G. Whittaker and C. Wilson, J. Chem.Soc, Dalton Trans., 1975 
(2003). 
198. V. E. Kaasjager, E. Bouwman, S. Goner, J. Reedijk, C. A. Grapperhaus, J. H. 
Kcibenspies, J. J. Smee, M. Y. Darensbourg, A. D. Kovacs and L. M. Thomson, 
Inorg. Chem., 41, 1837(2002). 
199. R. R. Fenton, R. Gauci, P. C. Junk, L. F. Lindoy, R. C. Luckay, G. V. Meehan, 
J. R. Price, P. Turner and G. Wei, J. Chem. Soc, Dalton Trans., 2185 (2002). 
200. Y. Xie, W. Bu, A. S. C. Chan, X. Xu, Q. Liu, Z. Zhang, J. Yu and Y. Fan, 
Inorganica Chimica Acta, 310, 257 (2000). 
201. Y. Z. Voloshin, 0. A. Varzatskii, T. E. Kron, V. K. Belsky, V. E. Zavodnik, N. 
G. Strizhakova, V. A. Nadtochenko and V. A. Smirnov, J. Chem. Soc, Dalton 
Trans., 1203(2002). 
202. A. D. Naik, S. M. Annigeri, U. B. Gangadharmath, V. K. Revankar and V. B. 
Mahale, Transition Metal Chemistry, 27, 333 (2002). 
129 
203. M. L. Cole, C. Jones and P. C. Junk, J. Chem. Soc., Dalton Trans., 896 (2002). 
204. N. Oishi, Y. Nishida, K. Ida, S. Kida, Bull. Chem. Soc. Jpn., 53,2847 (1980). 
205. Y. Nishida, T. Tokii and Y. Mori, J. Chem. Soc, Chem. Commun., 675 (1988). 
206. S. R. Cooper, Y. B. Koh, K. N. Raymond, J. Am. Chem. Soc., 104, 5092 (1982). 
207. R. Than, A. A. Feldman and B. Krebs, Coord. Chem. Rev., 182,211 (1999). 
208. C. Gerdemann, C. Eicken and B. Krebs, Ace. Chem. Res., 35,183 (2002). 
209. C. T. Yang, M. Vetrichelvan, X. Yang, B. Moubaraki, K. S. Murray and J. J. 
Vittal, Dalton Trans. J_13 (2004). 
210. S. Jain, N.K. Jain and K.S. Pitre, Metal-Based Drugs, 9,1 (2002). 
211. D. Zhu, R. Zhang, C. Ma and H. Yin, Indian J. Chem., 41 A, 1634 (2002). 
212. X. Song, Q. Xie and X. Fang, Heteroatom Chem., 13, 592 (2002). 
213. H. D. Yin, R. F. Zhang and C. L. Ma, Chem. J. Chin. Univ., 21, 1231(2000). 
214. H. D. Yin, R.F. Zhang and C. L. Ma, Models in Chem., 136, 333 (1999). 
215. H. D. Yin and C.L. Ma, chin. Appl Chem., 17, 375 (2000). 
216. I. Turel, I. Leban and N. Bukovec, J. Inorg. Biochem., 56,273 (1994). 
217. N. Raman, A. Kulandaisamy and K. Jeyasubramanian, Indian J. Chem. 41 A, 942 
(2002) 
218. B.J. Hathaway and D.E. Billing, Coord. Chem. Rev., 6, 143 (1970). 
219. B.J. Hathaway, Essays in chemistry, edited by J.N. Bradley and R.D. Gillard, 
(Academic Press, New York), 61 (1971). 
220. C. Shimokawa, S. Yokota, Y. Tachi, N. Nishiwaki, M. Ariga and S. Itoh, Inorg. 
130 
Chem., 42, 8395 (2003). 
221. J. Ruiz, R. Quesada, V. Riera, S. G. Granda and M. R. Diaz, Chem. Commun, 
2028 (2003). 
222. Q. Chen and D. Dolphin, Can. J. Chem., 81, 988 (2003). 
223. N. Fahmi and R. V. Singh, Indian J. Chem., 36A, 805 (1997). 
224. N. Gupta, R. Swaroop and R. V. Singh, Main Group Met. Chem., 20, 387 (1997). 
225. S. Satyanarayana, J. C. Dabrowiak and J. B. Chaires, Biochemistry. 32, 2573 
(1993). 
226. G. Yang. F. Z. Wu, L. Wang, L. NianFi and X. Tina, J. Inorg. Biochem., 66, 141 
(1997). 
227. G. B. Deacon and R. J. Phillips, Coord. Chem. Rev., 33, 227 (1980). 
228. K. H. Reddy, M. S. Babu, P. S. Babu and S. Dayananda, Indian J. Chem., 43A, 
1233(2004). 
229. J. Patole, S. Padhye, S. Padhye, C. J. Newton, C. Anson and A. K. Powell, Indian 
Journal Chemistry, 43A, 1654 (2004). 
230. P. P. Hankare, L. V. Gavaii, V. M. Bhuse, S. D. Delekar and R. S. Rokade, Indian 
J. Chem., 43A, 2578 (2004). 
231. N. Sengottuvelan, D. Saravanakumar, V. Narayanan, M. Kandasuamy, 
K.Chinnakali and G. Senthilkumar, Bull. Chem. Soc. Jpn., 77, 1153 (2004). 
232. M. Thirumavalavan, P. Akilan, M. Kandaswamy, K. Chinnakali, G. S. Kumar, H. 
K. Fun, Inorg. Chem., 42, 3308 (2003). 
131 
233. J. K. Tang, L. Y. Wang, L. Zhang, E. Q. Gao, D. Z. Liao, Z. H. Jiang, S. P. Yan 
and P. Cheng, J. Chem. Soc, Dalton Trans., 1607 (2002). 
234. J. Sanmartin, M. R. Bermejo, A. M. G. Deibe, O. R. Nascimento, L. Lezama and 
T. Rojo, J. Chem. Soc, Dalton Trans., 1030 (2002). 
235. K.K. Nanda, R. Das, K. Venkatsubramanian, P. Paul and K. Nag. J. Chem. Soc. 
Dalton Trans., 2515 (1993). 
236. N. Rajendiran, K. Ramalingam and R. Thiruneelakandan, Indian J. Chem., 40A, 
1101 (2001). 
237. Z. Y. Zeng, Y. B. He, L. H. Wei, J. L. Wu, Y. Y. Huang and L. Z. Meng, Can. J. 
Chem., 82, 454 (2004). 
238. Y. Z. Voloshin, O. A. Varzatskii, T. E. Kron, V. K. Belsky, V. E. Zavodnik, N. G. 
Strizhakova, V. A. Nadtochenko and V. A. Smirnov, J. Chem. Soc, Dalton 
Trans., 1203(2002). 
239. L. Bendahl, A. Hammershoi, D. K. Jensen, S. Larsen, A. Riisager, A. M. 
Sargeson and H. O. Sorensen, J. Chem. Soc, Dalton Trans., 3054 (2002). 
240. F. Liu. K. Wang, G. Bai, Y. Zhang and L. Gao, Inorg. Chem., 43, 1799 (2004). 
241. H. Xu, K. C. Zheng, H. deng, L. J. Lin, Q. L. Zhang and L. N. Ji, New. J. Chem., 
27, 1255(2003). 
